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I. 
INTRODUCTION 
The Institute of Bioinorganic and Radiophamaceutical Chemistry of the Research Center 
Rossendorf Inc. ( E R )  herewith presents its 1992 Annual Report to document research 
activities in the first year of its existente. 
The FZR, located 10 km to the east of the Saxon capital Dresden, took up work on 1 Ja- 
nuary 1992. So did its five institutes. The Institute of Bioinorganic and Radiopharmaceuti- 
cal Chemistry is thus in its initial Stages. Providing suitable working conditions, facilities 
and methods required substantial effort. Due to the new situation in eastern Germany, 
licensing procedures for handling radioactive material have become uncommonly difficult. 
However, thanks to manifold help and support, some ambitious aims have meanwhile been 
achieved. As part of the FZR, which is principally supported by the Free State of Saxony 
and the Federal Republic of Germany on a parity basis, the Institute has experienced most 
helpful support in the form of additional grants and a temporary increase in staff under a 
job-creation programme. The generous willingness of colleagues from various parts of the 
world to cooperate with us is highly appreciated. 
The Institute's research programme and profile are derived from an awareness of the very 
important advances taking place in modern nuclear medicine. Based on sophisticated 
radiotracers and focused on the molecular level, nuclear medicine offers unique oppor- 
tunities for studying tissue functions and translating the fmdings into ways of caring for sick 
people. To fully exploit this discipline of in vivo chernistry requires great commitment to 
interdisciplinary research in20 radiotracers and a thorough apprecidtion of the complexity 
uivolved. Contributions from radiochemistry, organic and inorganic chemisSr, radiophw- 
macy, radiopharmacology, physics, biology and medicine have all to be combined arid 
merge in tracer design. The Institute's profile is such %hat it is prepared for the challenge of 
sophisticated interdisciplinary work in order to gain a deeper insight into the fundmentals 
of the chernistry and biobehaviour of biochemical tracers. 
With the emphasis on biochemical processes, positron emission tomogal~hy 
essential modality for assessing the global and regional functional status ~f 
or other Organs of interest, In line with the recommendatiuns of tbe Scientül.~ C O W ~  
the Federal Republic of Germany, chemicd and biologied r e s a c h  into mdiotriacers will be 
cation of PET, will be conducted in caopt ior i  with the Dresden 
will i@alJy focus on dismses of th;e bMn, The ta.sk of es 
calls for substantial scientific, financial and administrative commitment - dominated the 
activities of the Institute in 1992 and will continue to do so in the years to come. 
Since single photon emission computed tomography (SPECT) continues to be the principal 
way of translating PET advances into broad clinical practice, specific SPECT tracers are 
one of the main subjects of research. An analogue concept of rational tracer design makes 
it possible to go from 1 1 ~  or 1% PET tracers to 1231 SPECT tracers. Such a straightfor- 
ward concept of development of biochemical tracers does virtually not exist for 9 g m ~ c ,  the 
workhorse of nuclear medicine. Technetium has an intricate coordination chemistry that 
does not go well with the organic nature of biochemical substrates. Overcoming this pro- 
blem as far as possible by gaining a better insight into technetium chemistry and exploiting 
its versatility is a cmcial task. 
With this aim in mind our Institute's SPECT tracer group has been concentrating on the 
chemistry of new radiopharmaceuticaily relevant technetium compounds. Research has 
focused in particular on the reaction of technetium with sulphur-donor ligands and the cor- 
responding products. They are considered to be of special value for a new generation of 
specific 9 g m ~ c  tracers. Analogous rhenium compounds have also been studied in view of 
their therapeutic potential. 
The two working directions - PET and SPECT tracer reseach - will be closely combined in 
the hope that they mutually stimulate each other and that biochemical tracer concepts of 
PET can bei tmnsfemed to technetium compounds, going from PET to SPECT. 
The aims and tasks as outlind above have given rise to the current stmcture and staffing of 
the Institute of Biouiorganic and Radiopharmaceutical Chemistry as shown in Scheme 1. 
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11. 
SUMMARY OF ACTMTIES AND RESULTS 
The subjects of our work are described in this volume in 27 individual reports devoted to 
various aspects of radiotracers for nuclear medicine. 
The first part contains a description of the setup of a PET facility, for which extensive 
efforts have already been undertaken. Its main components will be a new cyclotron 
(Cyclone 18/9) as a replacement for the present U120 machine, an automated transport 
System to Cover the distance of 500m to the radiopharmceutical labarotory with its three hot 
cells, radiochemical laboratories, and the medical section with a POSISOME IIIp PET 
camera. 
In addition to technological installations, the establishment of Good Manufacturing Practice 
(GMP) and analytic and synthetic work preparatory to routine preparation of 
radiopharmaceuticals, emphasis has been given to studying llc ring labelling of aromatics 
to obtain metabolically stable tracers. 
Miscellaneous topics include the quality of labelling agents, such as 1231 iodide and 9 g m ~ c  
pertechnetate, and software for pharmacological studies. 
The Papers on technetium chernistry are closely related to each other. Major activities were 
devoted to the synthesis and characterization of novel technetium complexes as wefl as io 
reaction routes and products in intricate technetiumlligand systems. Studies focused pri- 
marily on complexes with sulphur donor ligands: 
Earlier work on defined Tc(V)oxo complexes of dimercaptosuccinic acids was extended and 
produced new insights into the existente and behaviour of isomers and enzymatic cleavage 
of ester bonds in the dimercaptosuccinic ester complexes. 
Significant Progress was made in obtaiPring new complexes with Moether ligands. With bi- 
dentate thioethers, neutral oxotechnetium(V) complexes were synthesid and characterized. 
X-ray structure analysis reveais either single-bonded or bridging oxygen in t ras  position to 
the Tc-0 core as a characteristic feature of the new class of compounds, CIationie 
nitridotechnetiumfV) complexes with thiacriown ethers provide a new approach in ina- 
diotracer design. 
Fundamental studies with mercapto-conlainhg peptides wer6 contin 
signT5cant for the current discassion of new radiopharmaceugds. They are most hefpful 
for a better unrlersmding of the very sensitive interpiay betuveen the vasious donor atoins In 
the bioligmds dilr-ing complexadon of technetium 
Work on precursors and mined-ligand complexes was continued and intensified in order to 
improve the assortment of candidates for the bifunctional concept of designing new 
radiopharrnaceuticals. Preliminary investigations were carried out into metabolizable 
technetium complexes and redox-active markers as tentative studies in the search for more 
spmific tracers. 
m. 
RESEARCH REPORTS 
1. THE ESTABLISHMENT 03' THE ROSSENDORF PET CEN'IXR 
B. Johannsen, J. Steinbach 
lntroduction 
Positron Emission Tomography (PET) is unique in its ability to image and quantify 
physiological and chemical processes in human beings. More and more diseases are now 
being defined biochemically. Unitil now a research tool for studying the physiology and 
biachernistry of mainly the braini and heart, PET is also evolving into an applied clinical 
technique. The potentials of PET to characterize diseases in regional biochemical terms 
essentially depend on radiotracers. Development of new radiotracers has become more 
complicated and challenging. Extensive background research by radiochemists, 
radiopharmacologists and physicians is required before a new PET tracer can be used in 
diagnostics. As stated recently [I], PET is also a highly complicated imaging technology 
and requires someone who understands the problems and is still willing to do it, plus 
enough money to get the thing gaing. 
The new Research Center Rossendorf, which is located 10 km to the east of Dresden 
(Fig.11, provides excellent prerequisites and conditions for housing a PET centre for the 
Dresden region. With an adequate multidisciplinary profde of its own and strong ties with 
the nearby universities and rnedical institutions, in particular the Dresden Technical 
Urafversit-y and the Medical Academy, it has started setting up a PET facility, the first in the 
new federal states of Germany. 
Bichofswerda 
Center Rossendorf 
.J: 1Rossendor.f the Dresden region 
The installation and operation of the PET centre at Rossendorf greatly benefits from 
previous achievements in targetry, nuclide production with the U-120 cyclotron, applied 
research on positron-emitting nuclides and their compounds, preparation of 
radiopharmaceuticals, and experimental radiopharmacology, as well as the design and 
constniction of PET detectors and a special PET camera. As part of the Institute of 
Bioinorganic and Radiopharmaceutical Chemistry with its second focus on the chemistry 
and radiopharmacology of 9 9 m ~ c  ompounds, the PET centre makes it possible to combine 
PET and SPECT tracer research, aiming for a broader application through the use of 123~ 
and especially 9gm~c, the workhorse of nuclear medicine. 
0 Production of radiophar- . GMP 
maceuticals for routine use Medicine 
and on request 
4 Patients 
4 PET-Tomograph n Clinical e Radiochemistry 
0 Modelling 
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0 Data handling maceuticals 
Fig.2: Mu1tidisciplinarity of the PET centre at Rossendorf 
An important field .of research is the application of tracers in neurology and psychiatry for 
studying brain dysfunctions. Various basic and specifically prepared radiopharmaceuticals 
will be used for this purpose. 
Medical research will be performed in c l ~ s e  cooperation with the Dresden Medical 
Academy. There are two projects: 
Thefunction of the serotonergic system in psychiatnc diseases will be one subject of our 
joint work. The neurotransmitter serotonin is involved in the regulation of various 
physiological functions. Changes in serotonin metabolism play an important role in a 
number of psychiatric diseases such as depressions. PET Opens up the possibilities for 
investigating such changes and for assessing the effects of pharmacological intervention. 
The second project is concerned with a chamcten'~'on of myotonic dystrophies, which has 
been very difficult until now. This problem is of great importance, because patients 
suffering from this disease require lifelong care. There are some indications that changes in 
the brain glucose metabolism are involved. 
2. Developnient of tracers and radiochemical developments 
One goal of our research work is the development of radiopharmaceuticals labelled in posi- 
tions which are practically not metabolized within central fragments of the molecules. These 
are no -er added lk- labelled compounds, e.g. compounds containing cyclic fragmen- 
ts, especially aromaik rings. The details are described by Mäding et al. [this repo*, p. 181. 
The special irnportance of I8F labelled tracers is based on its suitable half-life (1 10 minu- 
te~). Bther cliniical PET centres withh a zadius of 3...4 hours' transport time can be 
repoiariy supplied with 18F-based radiopharmaceuticals (conception of satellites) . With 
regard to labelling procedures with electrophilic 18p, there is a strong demand for 
specialist knowIedge for generation of no-carrier-added in high yields md in new 
twhniques for the synthesis of appropriate radiopharmaceuticals. 
The PET technique is associated with certain characterizations originating in the short half- 
life of& radioisotop used and resulting in a very high activity level and the necessity of 
hmdlhg smdl amounfs of molecules. This specific: feature demands fundamental 
radiochemieal research, including hot synthesis, micro analysis and special equipment. 
4. Future prospects of PET in Rossendorf 
Thefunrre prospects of PET at ~ossendorf are bound up with the future of other parts of 
the Research Center. One of the future subjects of research - also in connection with the 
Dresden Medical Academy - is the treatment of Cancer. The light ion tumour therapy in 
particular requires a pre-therapeutic diagnosis (hypoxic state, pH-value), a therapy 
prognosis depending on the state of the tumour, and an evaluation of the therapeutical 
effects by PET. Similar requirements will have to be met for neutron and neutron capture 
therapy. The neutron capture therapy affords an opportunity of assessing the distribution of 
boron-labelled pharmaceuticals before neutron treatment. 
The doses absorbed with these methods can be calculated in advance with the aid of PET. 
Lavout 
Given the structure of operating facilities and existing components, such as a cyclotron 
building with the U-120 cyclotron and radiochemical and biochemical laboratories 500 m 
away from the cyclotron, the setup concept is designed to both complete the PET centre and 
to improve its potentials, operability, cost-effectivness and licensability. 
The completion includes as a key item the extension to tomography in biochemical and 
clinical research, which wili be jointly done in colloboration with the nuclear medicine of 
the university hospital. Fig.3 shows the layout of the PET centre. 
overall length: 500 rn 
Fig. 3: Compnents of the Rossendorf PET Center 
Cyclotron and targetry 
The U-120 cyclotron at Rossendorf is a fixed energy machine which has been in operation 
for 36 years now. It was built for the requirements of nuclear physics. Its main parameters 
are as follows: 
These are rnaximum parameters with respect to the beam current. This machine is expensive 
to run in terms of maintenance and energy consumption, its reliability and flexibility are 
External 
beam 
current 
p o r  arid the operational parameters instable. 
Max. beam 
current on 
PET-target 
To overcome these problems, a specially designed Siemens system for large-scale 
generation of PET radionuclides, based on the "CYCLONE 1819" cyclotron produced by 
B A ,  Belgim (Fig. $3, will be insWed this summer. For cost reasons it will be sited near 
the oldi cyclotron. The cyclotron building project and shielding requirements have been 
planned by tbe sibility of the Rossendorf PET group. 
3Che new machine is a compact cyclotron employing negative ion technology. Negative ions 
, 33-1 allow ex-ction of moze than 99.9 % of the beam. Such high efficiency results in 
reater safety for personnel and environment (low activation) and lower ninning costs. 
comgletefy automated with a highly reliable industd 
rShe System is qab le  of produciog the d e s w  compounds 
[l  8 ~ ] ~ 2 ,  [~~FIF- ,  [ lk]~@, [l3NINH3, [ I5019 and [ ~~o ]co~ .  [ 1 1 ~ ] ~ ~ ~  and 
[150]~20 can be generated too. 
Generation of various other radionuclides is in preparation. A beam line system to be added 
to the CYCLONE 1819, including control system, has been developed and will be delivered 
by B A .  The vertically movable target changing device, our own development, will be 
attached to this beam line. It is designed for eight target positions with a set of targets for 
gaseous, liquid and solid target materials. This is an important prerequisite for educational 
purposes . 
Capability for radionuclide production of the Cyclone 18/9: 
Radio- 
nuclide 
Haif-life 
(min) 
max. Activity 
(Gm) 
Transport systern 
As a special f a h r e  of the Rossendorf PET centre, the PET cyclotron and the PET centre 
are separated by a distance of 350m. A transport system for radioactive gases and liquids 
over 500m is therefore being installed on the basis of gas-capillaries and rabbit post linles 
(Fig. 5). This system, whieh works fully automatically, has been designed and csnstructed 
at the Research Center Rossendorf. The transport system and the synthesis units 
automatically driven by a SIMATIC system. 
I I /  ', J 
CYGLONE 1819 
tadiochemical laborai 
I 
hot celis 
;ii,s:,d I,II: rabblt system 
F@. 5: Scheme of the transport system 
Radiochemical research is based in a laboratory equipped with a double hot cell for tracer 
development. Precursor preparation and development of synthetic routes for hot synthesis 
are carried out in a laboratory for organic synthesis. 
All special equipment for radiochemical, radiopharmaceutical and biomedical purposes has 
to be of a high technical standard. Maintenance and further development are therefore 
important. A high degree of automation is also required for many procedures. In addition, 
the devices have to meet the requirements of safe operation, in particular with respect to 
I -adiation protection. 
Tomograph 
A PET tomograph POSITOME HIP* (Fig. 6) developed at the Montreal Neurological 
Institute was installed in June 1992. For further details see Will et al. (this report, p. 16). 
Fig.7: The PET tomograph POSITOME IIIp 
In addition to the usual techniques as required for tracer characterization and metabolite 
analysis, a comprehensive facility for experimental radiopharmacology already edsts. This 
inchdes binding assays for different (serotinergic, dopaminergic) ligands. The binding stu- 
dies are performed either on tissue preparations (brain homogenate, brain endothelial cells, 
cultured fibroblasts) or on tissue slices using autoradiographic methods. There are also se- 
veral biochemid methods for measurement of enzyme activities in various tissue prepara- 
tions. In vivo methods are also used. In addition to the traditional Organ distribution, 
etic models are being developed for in vivo characterization of radiopharmaceuti- 
cals. 
Schedule 
Phase I of the project is the replacement of the old U-120 cyclotron by the CYCLONE 
1819 for PET purposes and establishment of a temporary unit of nuclear medicine. 
Phase 2 envisages an expansion of the medical section by housing it in a separate building, 
and rearrangement of the laboratories in the radiopharmaceutical and bioehemical sections. 
1993:Completion of the installarion of the Cyclone 1819 PET-cyclotron. Reconstruction of 
a building as the permanent home of the Rossendorf PET centre' s medical section in 
conformity with the relevant pharmaceutical and medical regulations. 
1994:Completion of the automatic transport system for radioactive substances between 
cyclotron and hot laboratory. Some first items of equipment for automatic synthesis of 
important radioactive tracers will be developed and put into operation. 
1995:Installation of a whole-body PET-carnera. 
Reference: 
[I] Wagner, H.N., Jr. J.Nuc1. Med. 32(1991) 11N 
*Acknowledgement: We are deeply thankful for the outstanding support by the 
"Kulturstifiung Dresden der Dresdner Banlc" and the Montreal Neurologioal Institute 
2. INSTALLATION OF THE PET-CAMERA POSITOME IU[p IN 
ROSSENDORF 
W. Enghardt, H. Lineman, M. ~ a u a l ,  C .  ~ h o m ~ s o n l ,  E. Will 
l~ont rea l  Neurological Institute 
The PET camera POSITOME IIIp from the Montreal Neurological Institute (MN) arrived 
at Rossendorf at the end of 1991. This head tomograph, sponsored by the Kultur-Stiftung 
Dresden der Dresdner Bank, was developed and built by the group of C. Thompson in 1978 
and continuously modernized ti111986 [1,2]. 
The POSITOME IIIp has a high efficiency in comparison with other PET' tomsgraghs. Its 
high usable frame rate makes it especially suitable ffor dynamic brain studies. 
The tomograph was installed in the new medical section of the Rossendorf PET centre. One 
of the problems was the installation of a 110V power supply for the electronic equipment of 
the POSITOME Scanner. The first test of the detector system showd, that thene was no 
transport damage. Some adaptions were necessary on the bed in order ts comply with 
German safety standards. The final installation and testing of the POSITOME IIIp at 
Rossendorf t00k place in June 1992 in cooperation with C. Thompson arid M. Mazza from 
the MNf. We c e e d  out fme corrections for the gain, the threshold arid the ctrincidence 
window for all detectors. 
The programs for data acquisition and reconstmction were wfitten by C. Thompson [31. 
The reconstniction program runs on PDPll an~d VAX Computers. Image display arid 
analysis will be performed on a VAX with a Lexidata display after solWig some t ~ h n i c d  
problems. Time measurement in 
the acquisition and evaluation ------ upper - -......-,.-..-.. - lower 
programs is based on the power 
4000 
frequency, the time calibration 
3000 coefficients must therefore be 
changed from 60Hz to 50Hz. 
2000 For gutting all parts of the 
tomogragh and the aquisition pro- 1000 
g m s  hto Operation, calibration 
measutements and simulations of 0 
70 80 90 100 110 120 130 140 15O 
studies were perfonned using 1 8 ~  
and 221% sources. U s u e  6 8 ~ ~ -  position (nun) 
sources are used for POSBOME 1: h k i l  resolution measured for the lower-, 
IIZp cdibration, we u s d  1 8 ~  centre- and upper-slice with a 2 2 ~ a  sourCe 
phantoms. on the axis of POSITOME IIIp (in air). 
Tfie axial ire~olution was meam- 
rec~ with a 2 2 ~ a  sour= i,  
(Fig. 1). We obtained a resolution of 15mm FWHM for the lower and upper slice and 
13mm FWHM for the centre slice. The distance between the lower and upper slice is about 
35.5rnm. These vaiues are in a good agreement with the vaiues measured by C. Thompson 
at the MN1 121. 
The technical layout for the POSITOME IIIp is as follows: 
Number of rings: 
Number of slices: 
Number of detectors: 
Resolving time: 
Image resolution: 
Axial resolution: 
Maximum activity conc. : 
True count efficiency: 
Scatter fraction: 
Max. frame rate: 
Patient port: 
2 
3 ( 2 direct, 1 cross) 
64/ring, BGO 3Ox30x(22 to 18) 
18ns 
10.9mm (FWHM) 
15.9mm (FWHM) 
4 0 ~ ~ ~ 1 c m 3  in 20cm dia. flood phantom 
75kcounts/sec/(p~*cm3) in 20cm dia. source 
27% in 20cm diameter flood phantom 
26cm diameter 
References: 
[I] Thompson, C. J, d ai., IEEE Trans. Nucl, Sei„ NM6 (1979) 583 
621 Thompson, C. J, IEEE Trans. Med. Imag., MG5 No. 4 (1986) 183 
[3] Dagher, A, et al., IEEE Trans. Nucl. Sci., NS-32 (1985) 811 
3. SUBSTANCES LABELLED IN METABOLICALLY STABLE 
POSITIONS: 
INACTIK EXPERIMENTS FOR THE S ~ E S I S  OF 11 C-RING-LABELLED 
AROMATZCS 
P. Mäding, J. Steinbach, F. Füchtner, H. Kasper, K. Neubert 
During the last two decades a flood of 11~-labelled compounds were synthesized. Only a 
few are of significance with regard to their practical use. One of the reasons may be 
underestimation of the importance of the labelled atom's fate within the living body. 
Investigations of radiopharmaceuticals of the Same origin but labelled at different positions 
produce new biochemical information. An alternative way might be the synthesis of 
compounds labelled in metabolically stable fragments of the molecule. The metabolic 
pathways of these compounds should be lcnown or must be explored for their application. 
Aromatic fragments of molecules in particular were found to be metabolically stable 
components of compounds. Experiments with biologically active aromatic substances in 
biological Systems may be expected to produce long-living metabolites, including 
unchanged aromatic rings. 
There are many important biologicdiy active aromatic compounds, e.g. phenylalanine, 
tyrosine, DOPA, dopamine, adrenaline, ephedrine, arnphetamine etc. 
TO our knowledge only one experiment has been carried out to synthesize llc-ring-label- 
led aromatics [I]. In this study the classic synthesis of benzeneltoluene was modified via 
trimerization of carrier-added [11~]alkines. The result was a mixture of products with very 
specific activities (6OPmol acetylene for the synthesis of benzene) and low yields 
(about 25% benzene), which is unacceptable for our application. An early publication C21 
deak with the reaction of cyclopentadiene and 11~-atoms in hot arid thermal Systems. re- 
sp~tively- As described, mixtures of many different products were formed. The main por- 
consisted of polymers, but also [lklbenzene was produced in yields of 8-1 1 %. This 
kind of convetsion is also unsuitable for a specific synthesis. 
The f0110wing criteria must be considered for the synthesis of 11~-rin~-labelled aromatics: 
the limited avdability of 1 ll-synthones 
as few synthetic steps as possible 
* short seactiofi. times 
suecient radiochemical yields. 
In prhc$e, the v a r h s  possibiliöes of synthesis are: 
Conversion af synthesked I1c-&$-~~b~tituted 5-rings (substituted cyclopentanes, cy- 
clopentacaiena) or 1 lc-fing-labelled 6-rings (cyclohexmes, cyclohexenes, cyclohexa- 
by means of catalytic, thermal or chemical processes (reactions of jsomehzation, 
zation) in& 11~-~ng-labelled 6-fing aromatics 
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Synchronous six-electron cyclization of hexatriene systems into aromatics. 
The last mentioned synthetic method represents a promising basis for the synthesis of mani- 
fold lC-ring-labelled aromatic compounds because of the possible variation of substituents 
at the inactive precursor. 
The synchronous six-electron cyclization of hexatriene systems into aromatics takes place in 
two steps [3]: 
1. thermal cyclization of hexatrienes into cyclohexadienes as a reversible process 
2. irreversible conversion of cyclohexadiene into a 64ng aromatic by means of an elimi- 
nation step if the starting hexatriene has got a suitable leaving group, e.g. a dime- 
thylamino group, preferably trans at C-1, and additionally a cis-proton at C-6: 
Our first aim is to synthesize llc-ring-labelled phenylalanine, We therefore developed a 
suitable way for synthesis of phenylalanine, Prerequisite for this synthesis is the availability 
of [lklnitromethane, which can be prepared according to [4,5] by reaction of [ ~ ~ C I M ~ I  
with AgN02. In inactive experiments, the following route of synthesis was tested and 
optimized as a one-pot process on the 2mmol scale: 
In the presence of a base (NEt3) nitromethane as a C-H-acid compound reacts with the 
pentamethinium salt 5-dimethylaminopenta-2,4-dienylidene-dimethylmmoniumper~h~o- 
rate into 6-nitro-l-dimethylamino-hexatriene and dimethylamine. The cyclizationl 
aromatization into nitrobenzene occurs by elimination of the second dimethylamino 
group at increased temperature 133. The synthesis was carried out in DMF at 1OODC, 
The nltrobenzene form& war reduw with N W 0 4  in boi1ing 
161: 
4. This was followed by the so-called "Meerwein arylation" of acrylic acid with the dia- 
zonium salt, with formation of a-bromo-B-phenyl-propionic acid. This reaction occurs 
with CuBr as a catalyzer at room temperature [7J: 
CuBr 
Br 
I P~-N=NBL H 2C=C-COOH PhCH -C-COOH I 4 2  2 1 
H H 
5. The desired phenylalanine was formed by ammonolysis of a-bromo-B-phenyl-propionic 
acid while refluxing 13: 
The Course of the reactions was followed by HPLC. , 
The processing of the reaction mixture occurs as follows: The reaction solution containing 
an excess of ammonia is evaporated. The acidified mixture is introduced onto a column of 
cation exchange resign (Wofatit KPS, 8% DVB, 160-320pm, H+-form, neutral). In this 
way all inorganic saits and organic products without arnino groups can be separated by 
washing with water. The synthesized phenylalanine can be eluated with diluted NH3 
(2.5%). Further colurnn-chromatographic pufification can be performed after evaporation of 
the NEQ solution (conditions: silicagel 60 (0.2-OSmm, Merck)/water followed by 
LiChroprep W-18 (40-63pm, Merck)/water). In this way colourless crystalline 
phenylalanine can be obtained. 
Andyzing thin layer chromatography O[ZC) was performed on silufol Wavfier, CSFR). 
The plate was developed in acetonel MEK/NH3/H20 = 60 : 30 : 20 : 10. Phenylalanine 
C a n  be visualtzed as red spots on spraying the chrornatogram with ninhydrin solution and 
heating. The System of TLC plates RP-18 F254~ (Merck)/water is also suitable for this 
problem. 
This overall procedure will be adapted to the use of [ 1 1 ~ ] ~ ~ 3 ~ 0 2  in the near future. 
The necessary inactive prmrsor for the synthesis of phenylalanine, the Idimethylmi- 
nopenta-2,4-dienylidene-dimethylammonium-rchlorat, can be prepared as fohvs:  
e PS reacted w i h  1-chloro-2,4-dinitrobenzene to form N-[2,4-dinitr0phenyl)-~~- 
ndinium ~hloride 187: 
2. The pyridinium salt formed is very unstable in the presence of bases, which Open the 
pyridine ring by removing the pyriaine nitrogen. Reaction of this pyridinium salt with 
dimethyl-amine produces the 5-dimethylaminopenta-2,4-dienal, a so-called menocyanine 
and 2,4-dinitroanillne 193: 
3. The merocyanine reacts with dimethylamine perchlorate to form the desired penta-me- 
thinium-salt, a so-called azacyanine, by elimination of water lgl: 
The structures of the merocyanine and the azacyanine were c o n h e d  by 1 3 ~  NMR-da@. 
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4. IONCHROMATOGRAPHIC DETERMINATION OF THE RADIO- 
CHEMICAL PURITY OF ~ 1 2 3 1 1 ~ ~ 1  SOLUTIONS 
F. Füchtner, C. Kretzschmar, R. Scholz, J. Steinbach 
Introduction 
Radioiodine has been produced for decades for a wide range of uses. One of its main 
applications is the labelling of radiopharmaceuticals. Sinee the late seventees 123~ has 
become more and more important. Its characteristics are a low radiation dose ( only 1 % of 
that of 1311 ), a suitable y-energy (159keV) and a favourable half life (l3.3h). 1231 should 
be produced by the 1 2 4 ~ e  @,2n) 1 2 3 ~ s  +- 1231 process. This is the only way that allows 
generation of a product of very high radionuclide purity. 
For labelling purposes the iodine has to be of special quality in terms of radiochemical as 
well as chemical purity. 
We studied the radiochernical purity of the [l%jNaI solution produced at the Nulclear 
Research Centre Karlsruhe for commercial purposes. Owing to oxidation by radiolysis and 
oxygen all [123u~a1 solutions without stabilizers contain iodate [I03-] and, after a 
prolonged storage, periodate [104-1. Another quality marker is the specifie activity of the 
solution, i.e. the relation of radioactive and stable forms of iodine. 
* 
The aim of this work was to find an analytical method for determination of the 
concentration of the various stable and radioactive iodine species. This method has to meet 
the following demands: 
- short analysis time, 
- simple handling of radioactive samples, 
- small sample volume, 
- low detection limit (1% of the starting concentration is equivalent to approximately 4 h M  
01 Sppb 103- or 104-), 
- fie results have to be reproducible. 
An ion-exchange method performed with the help of an automatic liquid-chromatographic 
System is expected to meet these demands. 
The problem associated with the simultaneous determination of the various iodine species is 
the Separation of anions of very different selectivities in a short analysis time and in low 
~O~centratiogs: 
The h?ate ion has a short reteniion time and is eluated near the dead volume of the column. 
Iodide l.eacts in a different way. It is very hydrophobic m d  strongly interacts with the ion 
exchang.er [I], On most commercid columns, mainly developed for environmental analysis, 
fhe bcWe i o ~ s  hwe a high retenticm time and are usually not eluated as a detectable P&. 
The retention increases more than proportionally to the capacity of the column 121. 
Periodate ions may exist in the solution in the meta, meso and orthoform and we can 
therefore expect a higher charge of the anion and accompanied this by a strong retention. 
A column of a low capacity should therefore be used. The ion exchange columns used were 
made by modifying a hydrophobic support with strong lipoidic ionic substancw. For anion 
chromatography it is possible to coat silica-based RP(reversed phase) materials with dkyle 
quartemary ammonium salts. 
Determination of radioactive impurities is carried out with a simple scintillation NaI(T1) 
crystal. This detection system works with reproducible results up to 740MBqlSOp1 
[1231]iodine radioactivity level. 
As there was no possibility at the time to work with real radioactive solutions inactive 
investigations to optimize separation conditions were carried out. 
Experimental 
For the investigations an HPLC system (Merck-Hitachi) was usd ,  ineluding a pump, a 
manual injection valve with 20p1 sample loop, a column thermostat with column arid a 
UVIvis detector. 
As RP-18 support material we applied LiChrospher (5pm), Superspher (4pm), EnVisil 
(4pm) and Separon (7pm). The glass columns (150 X 3.3mm; LP-Prague) were fdled with 
the Supports by a sluny technique. In order to achieve ion exchange properties, a sojution 
of the quartemary ammonium salts was pumped through the column up to eguilibrium. 
During the process of coating a definite capacity was produced by using different kinds sf 
salts (cetyl-trimethylammonium bromide (CTMA-Br), tetra-n-octylammonium bromlcfe 
(TOA-Br) or tetra-kisammonium bromide (TKA-Br)) and different concenü1atbns of the or- 
ganic modifier 
(50 - 80% acetonitrile/water), The capacity of the ion exchmgers was determind by the 
UV break-through curve while modifying or quilibrating the column with a UV absorbiYlg 
ionic solution. 
For elution we used different solutims of cftric acid and H2P */HPO$ buffer @H 4.. .7. 
equilibrated with NaOH) and Na2S04 @H 3.„3, quilibrated wih H$O4) in the 
concentration rangt2 of 1 to 10mmoV1. 
Detection was accomplished by measurkg the UV-absofpition sf iodate, brodde and mitrate 
at 205nm, while 225nrn is more suitable for detection of iodide and pdoclaie. 
To detennine separation factors and to estimate Interferenm~ witb a&er pss ibk  mioni~ 
impunties, we dso used chloride, brumide and &rate in inhe stanrdatd S O ~ U ~ O E S  in a 
concentration mgi: of 0.1 to Immolllf. 
The most effective chromatographic separation was obtained with the supports LiChrospher 
and Superspher. In the chromatograms with EnVisil all peaks have a tailing. Using columns 
filled with Separon, the backpressure was too high after modification so that the analytical 
times increased too much. 
For an optimal separation we used a colurnn with a capacity of about 10.. . 40pmol/g. 
Applying Na2S04 solutions as eluent the iodide peak shows a strong tailing, which cannot be 
reduced either by application of the varioas support materials or by modification with 
quarternary ammonium salts of various alkyl chain lengths (hydrophobia of the functional 
groups of the ion exchanger). The tailing was only reduced by application of an eluent with 
pH ~5.0. At a pH value 56 a reduction of periodate is observed during analysis. When 
examining penodate in the chromatogram, an additional iodate peak is detected. At a pH 
value of 4.0 only iodate is found. 
The optimum pH value is 5.5. No significant reduction of periodate occurs at this values, and 
iodide and periodate are eluted with only a small tailing. A 1mM solution of citric acid 
Proved to be a suitable eluent of suffcient elution strength. The chromatographic conditions 
are shown in Fig. 1. The analysis is carried out within 10 minutes. 
Absorbance [AU] 
030 , I 
Br- 
L 5 
Fig. 1 
analytical column: 
ion exchanger: 
eluent: 
detection: 
sample: 
d~ = 3.3mm; L = 150mm 
LiChrospher RP-18; 5pm; 
L; T = 25 "C; 
coaeed with 5 mM TKA-Br ln 80~01% acetonitdle; 
capaciiy: 2lPM/colum; 
1mM citric acid; pH 5.5; 
flow-rate:: 0.8dmin; p = 9.8MPa; 
1 - 103', 2 - Br-, 3 - NOg, 4 - 1-, 5 - 104"; 
V 
Peak 1 - 3: 205nm; Peak 4 5: 225nm; 
injection volume: 20~41 
1,2, 3, - 0.lmM; 4,5 - 0,zrPiM 
5. CONCENTRATION AND PURIFICATION OF PERTECHNETATE 
SOLUTIONS BY CHEMICAL METHODS 
S. Seifert, F. Schneider; G. Wagner 
There are a lot of attempts to produce (n,y)99~o/99m~c-generators with sufficient ra- 
dioactive concentration of pertechnetate eluate for nuclear medical use. 
Because of the high content of inactive molybdenum in the irradiated Mo03 large generator 
columns containing alumina are needed. 
That results in large elution volumes containing relative high Mo contents and low ra- 
dioactive concentration on 99m~c. 
For these reasons a simple and convenient method for concentration and purification of 
pertechnetate solutions may be desirable. 
The methods used in the laboratory are either expensive (sublimation) or have the disadvan- 
tage that the resulting pertechnetate solution contains impurities of the extracting medium 
(extraction with methylethylketone) which decrease the labelling yield. 
To overcome these drawback, two different methods have been tested: . 
Complex formation with following adsorption and reoxidation 
Reduction to "Tc-hydroxide" with following adsorption and rwxidation. 
Complex formation 
Tc forms a reactive complex with ethyleneglycol (eg) in alkaline solution. The Tc(V)-com- 
plex RcO(eg)s]- is commonly used as a precursor for the syntheses of other Tc-complexes 
[I]. Its preparation is also possible in a large volume at n.c.a. level and pH 12 by reduction 
of pertechnetate with 0.05ml stannous chloride (lmglml ethanolic solution) in the solution 
of 0.5ml eg in 50ml pertechnetate generator eluate. 
The Tc-eg complex is stable in ligand excess over some hours and can be adsorbed on Se- 
pfraclex G 1QO. By washing with water the ligand excess is removed and the Tc-eg complex 
decomposes on the adsorbent. After 1-2h the Tc is oxidized to pertechnetate and can be elu- 
ted fiom the Sephadex column. 
The method described is a possible way of concentrating pertechnetate solutions but the 
procedure takes a long time and the yield is only about 50-60%. 
Reduction to "Tc-hydroxide" 
The reducticm of [99m~c]-patechnetate solutions with a suitable reducing agent in con- 
nection with the adsorpdon of the "reduced hydro1ym.i technetium" represents a better me- 
Bad for concentration. 
The most suitable reducing agent is stannous chloride. 50pg allows a quantitative reduction 
of pertechnetate at n.c.a. level also from big volumes of 50-100ml in a short time of 1- 
2min. 
For adsorbing the "Tc-hydroxide" different materials were tested (alumina, glass spheres, 
glass filters G4 md G5, cellulose acetate filters). 
The most promising results were obtained by using alumina. The reduced hydrolyzed 
technetium is adsorbed quantitatively on 1-2g alumina (98.4% adsorbed Tc-hydroxide 
evaluated by 20 experiments). 
For reoxidation of Tc(IV) to Tc(VII) we studied treatment both with H202 in ammonia and 
oxidation by nitrate ions at higher temperatures. 
For oxidizing the reduced technetiurn on alumina 2-3 drops of a 25% H202lammonia solu- 
tion are sufficiernt. After evaporation of H202 the pertechnetate cm be eluted by 2-3ml iso- 
tonic saline. 
It is known that dkali nitrates lose oxygen during heating. Sodium nitrate adsorbed on alu- 
mim gives up which decomposes to NO and 0 at temperatures > 14WC [2]. The 
native oxygen should be able to oxidize the Tc(1V) to Tc(VII), which can be eluted from 
alumina. 
Fig. 1 : Dependence of the non-eluable 
Tc-activity on the reoxidation tempera- 
ture (aluminaJNaN03) 
We tested NaN03 and FJH4NO3 and found that 
both compounds oxidize more than 95% of the 
Tc(IV) to Te(VI1) at temperatures CI3W0(d 
1 )  The ehtiori of pertechneiate is 
quantitative only by using alumina. 10-20% of 
the Tc activity remaits on the column if other 
adsorbing materhls are used- 
Whithout nitrate only less firn 2% of TC-hy- 
droxide is oxidized at 3üOOC. A sufficient 
amount of fitrate is adsorbed if &e duminina Is 
washed with a 03 NdY03 sohtion before 
adsorption of Tc-hydroxide. If pertechnetate is r d u d  in 0.9% NSO3 solution ~ i f i  Skin- 
nous chloride, the low Cl--concentration does not interfere witfi rmxidatiun. 
The oxidation of Tc(N), adsorbed On alumina, by nitrate ions represeats a sui'tabk ~nra&od 
for concentration and purifimtion of netate solutions. In on wtth a simple 
equipment, simllar- to a commercid generator, It should be r~.ppfi& if fis3ion sn~lybrlenurn 
generators are not aMablee 
6. COMPARTMENTAL ANALYSIS OF BLOOD-BRAIN TRANSFER AND PROTEIN 
INCORPORATION OF L - [ 7 5 ~ e ] ~ ~ ~ ~ ~ ~ - ~ ~ ~ ~ ~ ~ ~ ~ ~ ~  IN RAT BRAIN 
R. Bergmann, P. Brust, G. Kampf, M. Kretzschmar, H.H. coenenl, K. ~amacher l ,  
G. ~töcklinl 
l~nstitut fur Chemie 1, Forschungszentrum Jülich 
Different attempts have been made to measure the rate of protein synthesis in the brain with 
positron emission tomography (PET). Usually [1k]-labelled amino acids with a half-life of 
20.48min, e.g. ~ [ l ~ ~ l l e u c i n e  or [1 lclmethionine, are used for this purpose. Also [ 1 8 ~ ]  
labelled amino acids are recommended for the evaluation of protein synthesis by PET. 
However the synthesis yields are relatively small. In methionine the sulphur atom may be 
replaced by the positron-emitting [73se] or the y-emitting [75se] with half-lives of 7.15h and 
1 19.78d7 respectively. In principle, selenium-labelled methionine should be appropriate 
particularly for studying long-time metabolic processes like protein synthesis with PET. In 
order t o  check this possibility we have studied in rats the blood-brain transfer, protein 
incorporation and metabolism of L-[75~e]selenomethione (SeMet) with high specific activity. 
Methods 
The experiments were perfonned on 42 male Wistar rats. The animals were slightly 
anaesthetised with ether. SeMet (SOOKBq, > lOCi rnrnol-1) (1) was injected i.v. and the rats 
were decapitated at 14 different times (3 animalsltime) up to 360min p.i. The brain was 
removed m d  imrnediately stored in liquid nitrogen. Blood and plasma samples were put on ice. 
All plasma sample and brain samples at 1.5, 5.1,20, 120, 240, and 360min were analysed for 
labelled fractions of free SeMet, metabolites, and SeMet bound to t-RNA and proteins. A 
three-compartment model was applied to the data to  calculate the blood-brain transfer 
constant, KI, as well as the rate constant of SeMet incorporation into proteins @3) using the 
feilowing equations: 
U1 
arid Mp are the amounts of fiee SeMet and SeMet incorporated into proteins, 
respectively. M, represents the amount of [75~e]  bound in proteins and diierent metabolites. 
The rate constants k3 and kq were calculated directly fi-om equation 1 using the measured 
mounts af fiee and prutein-bound SeMet in the rat brain. These constants were used in 
equation 2 to ~ d c u I a t e K ~  and k2. 
Results 
The means of the measured values are listed in Tab. 1. The rate constants k3 and kq estimated 
fiom equation 1 are 0.020 * 0.003min-l and 0.003 i 0.001min-1, respectively. From equation 
2 the blood-brain transfer constant KI was calculated (0.15 1 I 0.03 lml g-l min-l). The rate 
constant of brain-blood transfer was 0.124 * O.OO6min -1. 
Tab. P : Amounts of L-[75~e]selenomethione (nmoWg) in plasma and brain at diirent times 
after injection 
Comments 
The kinetic constants obtained in this study ate on the one hand higher (KJ) and on ihe other 
hand lower (k3 and kq) than those measured recently in anmthetised dogs with L- 
[' l~]methionine (2). Different affinties to binding sites (transporter, enzymes) ur spenes 
differentes may be the reason for this. The apparent hcoqporation rat@ of rn-eihionsne Ss 
expected to be about 0.6nmoVminlg in our studies, assuming a w t e n t  af fiee iendogmous 
methionine in the brain of 28nmoVg (3). This is very close to vdues obtauied with L- 
[35~]methi~nine (0.68 nmoWmin/g) in rats (4). It is ~ncluded from the studies that L - [ ~ ~ s ~ ] -  
selenomethione may be an appropriate tracer for measurin$ br8k protein synth&& w&h PBF, 
Supported by grant No. 41543309 (WU9DO); WBIL 03 l a  / Fcfrsckungszentnxm 4uiirr-h -GmbH. 
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7. APPLICATION OF AN IMAGE PROCESSING SOFTWARE FOR 
QUANTITATIVE AUTORADIOGRAPHY 
E. Sobeslavsky, R. Bergmann, M. Kretzschmar, U. Wenzel 
The present cornmunication deals with the utilization of an image processing device for 
quantitative whole-body autoradiography, cell counting and also for interpretation of 
chromatograrns. 
It will be shown that the system pararneters allow an adequate and precise determlnation of 
optical density values. Also shown are the main error sources lirniting the applicability of the 
systern. 
Extensive biological research requires high speed image processing techniques to promptly 
manipwlate and analyse images. Such systems are realized both on the hardware and on the 
software sector. They improve accuracy and reduce the time required for analysis. Examples of 
application in biochemical research are cell counting, visualisation both of organizing and 
fiincticoning of the brain etc. A broad fidd of utilization is autoradiography in receptor-ligand 
studies, see e.g. 121, in chromatography or in investigations of tissue sec-tions. 
The images being investigated are captured by an optical acquisition system (converting a 
source image to a digital one) and in a following step manipulated by the image processing 
software V I S I L O G ~ ~  [I]. This sofiware is able to produce e.g. a number of statistical 
measures of the incoming image data including ensemble averages, variances, minimail maxima 
etc. 
Fig. 1. System configuration 
The acrtual system configuration to run V ~ S T L O G ~  is composed of a standard IBM 
compatible PC (486DX133 MWz+246KB Cache), a display device, a control terminal, fiom 
which ane issues commands to the system, an acquisition device offering camera input by a 
video camera (SOW, CCD Video Camera Module, HN Version, model XC-57CE) and 
image digitahatiori. 
The actual design should be preferably applied to quantitative autoradiography, it should be 
used to characterize cell agglomerations also. Autoradiography appears to be suitable to test 
the given image processing device because of its precision, 
As a first step one has to find out how the system responds to a well defined sequence of gay  
values related to the optical density of the autoradiogram. With this standard curve in hand, the 
optical density of autoradiograms produced fiom radioactively labelled thin tissue sections can 
be quantitatively converted to radioactive concentration. 
The sequence used for testing the system was available as Amersham autoradiographic [3fl] 
micro-scales [5] calibrated for a range of tissue equivalent values approximately of 1.4 - 32.0 
nCi/mg. A log-log linear relationship exists between tissue equivalent tritium content and the 
correspondiig optical density. 
The film was placed on a illurninated screen, cf. Fig. 1, digitalized and for fiirther use stored in 
the image memory ("incore processing storage"). It can be visualized on the display screen if 
necessary. Once the image is captured, processing does not depend on the actual conditions of 
the image acqusition (e.g. time of recording, adjustment of the camera lens, illurnina&on of the 
screen etc. ). 
Care has been taken to exclude a feed back of the TV carnera, One has also to take into 
account that the response of the camera is related in a non-linear manner to the illuminant 
intensity of light which stnkes the phototube of the camera, e.g. [3]. 
As a next step regions of interest (ROI) were specified for every gray level available on the 
film. The image processing system now computes the histogram and the intensity eenzered 
moments of order one to four over the region sdected before. Such 
measurements provide increased statistical confidence as compard io inlrlividuat spot or gsint 
measurements and compensate for randam noise variations. 
Fig. 2 represents the system response on a gray level StageJ see above, The curves B~Q'OY %hat 
one has to interpolate between non-linear regions if ane wishes to detednr: the relafionsitmip 
between the arnount of radioactivity and the Computer generated d opticd denWtier;. 
The reprodttcib'iity of the calibration cuWe is fairly satisfa~mrly, 
listed in Tab. 1. 
~ 
Tab. 1. Error sources characterizing the actual image processing device 
errors within an given gray level of the 5% - 10% 
calibrating rnicro-scale film 
errors outside a gray level, e.g. scratches, 
camera etc. (i.e. errors from the bare1 I 
I 
3% - 7% 
shadows on the film 
errors resulting fiom the optical System, TV 
illuminated screen without the film) I 
3% - 5% 
errors originating fiom outer conditions, e.g. I 1% I 
On the present status of work no attempt was made to exclude inhomogeneities in the screen 
illumination nor to exclude undesired high frequency (e.g.scratches) and low frequency (e.g. 
shadowing) perturbations on the film itself Note that VISILOG~M is able to provide such 
corrections. 
time of recording, power fluctuations etc. 
errors from individual choice of ROI (regions 
of interest) by the Operator 
The problem of counting cell agglomerations was attacked by help of a very simplified model.. 
1% 
Here the precision of intensity detemination seems not so crucially affect the measurement as 
in a smooth density change typically for autoradiography. 
For higher comfort a VISILOG~M playback routine could be used to combine successive 
operations on the investigated images. Most of current problems, however, need to 
interactively operate on VISILOGTM functions. So the applicability of such routine is rather 
limited. 
image analysis usually provldes large quantities of analysable data. So VISILOGTM allows to 
include the image functions in a C-language (version 4.0 and above) or in a FORTRAN 
program to use the results of analysis for subsequent mathematical interpretation, storage on 
external Gles ete. At the present, however, early Stage of investigation no use was done of that 
possibility, 
As an example f"or the use of quanitative autoradiography (QAR) served the biodistribution of 
the antimhyemic compound Bonnecor labelled with 1 4 ~ .  A Wistar rat weighing 170g was 
q of 1 4 ~ -  Bonnecor (3-carbeth~~amino-5-d'1l~1eth~lamino-~l-14- acetyl- 
[kfl azepine hydrochtoride). 24 hours after application the rat was 
sacrifed and a whole body autoradiography was pedormed as described by Wberg li.f. The 
optimum exposure time for the 50pm thick fieeze dried cryosections on the ORWO W64 X- 
ray film was eleven weeks. 
A stock solution of benzylic acid-1,l [ I ~ c ]  dimethylpiperidinylesteriodide containing 296 
kBq1ml served for the preparation of radioactive standard scale. From this a series of dilution 
were made in a geometric order in the range from 296kBqlml to 259Bqlml. Strips of FND thin 
layer chromatography foils with 50pm cellulose coating wer@ immersed singly into the 
radioactive dilutions. The dried impregnated strips were mounted parallel on plastic foils in the 
correct order of dilutions and exposed along with the 50pm thick dried whole body 
cryosection for varying lengths of exposure on ORWO RF64 X-ray films. 
Using the VISILOGTM image processing system to analyze the autoradiograms we rneasured 
the average optical density values over the entire standard area, From these measurements, ws 
constructed exposure curves relating optical denslty to 3qlg tissue equivalent, 
Tab. 3 presents radioactivity data derived fiom autoradiograms of whole body sectim and 
radioactive scale, respectively, exposed along on X-ray RF 64 ORWO film for eleven wecks. 
Results obtained by the actual V ~ S I L O ~ ~  confiprntion agres fairly weU with liquid 
scintillation spectrometry data and with visual observation. 
Tab. 2: Calibration of autoradiographic r3I3j micro-scales (Amersham), cf [ 5 ] .  
The table demonstrates that the calibration of the given system remains fairly 
reproducible for altered recording conditions (egtime of recording, power 
fluctuations, adjustment of the optical system), see column (a), (b), and enlargment, 
case (C). 
tissue 
equivalent 
optical density of the gay  level staircase in a scale of 255 density units 
(4 
1 pixel=1.013 X 10-2 Cm 
9ptical density of the 
;lluminated screen 
~i fhout film: 
= (224 f 8 ) units (of 
255) 
(C) 
1 pixel = 1.244 X 10-2 
[ = (224 f 8) units (of 
1551 
I = (182 f 9) units (of 
Tab. 3.1. : Biodistribution of Bonnecor rnarked by 14c. 
Calibration of the gray level staircase. 
- 
Level 
1 
2 
3 
4 
5 
-
Tissue equivalent, optical density as measured by 
J scaie 
i I 
Tab. 3 -2: Biodistribution of Bonnecor marked by l 4 ~ .  
Organ 
Content of iritestines 
Liver 
Kidney : 
total 
inner renal cortex 
extemal renal cortex 
calix ofthe kidney 
renai medula 
Testicle 
- 
optical density as 
180 
160 
140 
- see Tab.2, case (b) 
120 
100 
80 
60 
40 
20 
10 15 20 25 
tissue equivalent in nCL/mg 
Fig. 2. Standard curve for 4 weeks exposure time. Abscissa represents tissue equivqlent 3 ~ -  
concentration, and ordinate - the corresponding optical density values (in a 255-degree 
scale) for each of the eight activity levels in a [ 3 ~ ]  micro-scale, cf. [ 5 1. 
Fig. 3. Whole body autoradiogrm of a rat 24 h after oral appfication of 1.1 MBq 
1 4 ~  - Bonnecor, expssure time 11 W&, see text 
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8. DEVELOPMENT OF A LABORATORY INFORMATION MANAGE- 
MENT SYSTEM (LIMS) FOR RADIOPHARMACOLOGICAL 
RESEARCH PROJECTS 
E. Zugehör, R. Syhre 
The charactenzation of radioactive preparations in vitro and in viv0 requires a wide 
spectmm of radiochemical and analytical, biological, biochemical and animal experimental 
methods. Such methods produce heaps of highly diversified data and information, including 
those required to meet legal obligations. This information hase to be managed, .processed 
and documented efficiently and reliably. Commercial programs do not exist for that 
particular range of functions. The extent of functions cannot be realized with simple 
database programs like DBASE (Ashton Tate Corp.). A Laboratory Information 
Management System (LIMS) was therefore developed. This System is based on OBJECT 
VIEW Watesys Corp.) as a database development system and EXCEL (Microsoft Corp.) as 
a table calculation component. 
Tasks und Requirements 
LIMS includes the following functions: registration, calculation, documentation, book- 
keeping and management of various laboratory data and information in large numbers. 
Flexible association of data as well as guaranteed permanent and central access to data and 
results are essential requirements for research projects and have to be met by an LIMS. 
Attention to secunty and authorization are necessary. Up-do-date book-keeping and 
archiving of data are required to comply with legal stipulations. 
Concep 
LIMS is based on window applications, specified by the experimental method used. It uses 
a common database as well as common program routines to manage and process the data. A 
relational model was chosen to describe data, data relationships and consistency . The result 
is a specific set of tables for each method, connected logically through references. The 
windows front end database development system OBJECT VIEW (Matesys Corp.) was used 
for application of the model . The main advantages of this system are: 
Interface to QuadBase SQL with Security and Authorization, Transaction Processing, 
Referential Integrity (SQL=Structured Query Language, the smdard relational database 
lw3%e) 
Optimized access to Micrasoft/Sybase SQL Server 
* Visuaf Tnteda~e to create objects on the screen 
High Level Functional I[nteIface for associating a method with an objmt 
Level Functionai Interface, optionally in Object- View BASfC or C 
38 
Interface for EXCEL, WORD (Microsoft Corp.) and other window applications which 
Support the DDE protocol @DE=Dynamic Data Exchange) 
The structure of an application developed with OBJECT VIEW may be illustrated by a 
staircase model (Fig. 1) 
Windows Application Layer 3 
I I 
Layer 2 
Layer 1 
Layer 0 
Fig. 1: Staircase model of an LIMS Application 
Layer 0:SQL Database (SQL=Structure Querry Language) 
Layer 1:SQL Components @DL=Data Definition Language, DML= Data Manipulation 
Language, DTP =Data Transaction Processsing) 
Layer 2: Visual and Functionai Interface 
Layer 3: Application Layer 
Application 
As a frrst application a SQL Tod was developed . The user can woxk with the database 
without any knowledges of the database language. Convenlent inserting and 
tables and views is provided. For data input, output and pxocessing the standard calcblhtion 
program EXCEL (Microsoft Corp.) was fully included into the SQL Tool . The SQL Tod 
is not only an important part of the LIMS, but has also been used for programs i&e 6fl- 
ancial calculations and registers of chemicals and Iibrature. 
For animal experiments, i.e. investigation of the biodis2nbugon and bioBnedcs of 
radioactive preparations, a relationai data model was deveIopE.zl arid htegmtd itit0 a 
database. Fig 2. shows the componerits of the database application, ihat M bbe 
the User according to the individual scope of hctions, 
expenment 
spec. data measuring 
vrotocols 
predefmed 
pararneters 
I I relational create SQL database 1 
I 
. . 
% i'' 
measuring values 
Fig. 2: Integration of an experimental method into an LIMS 
data 
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9. HPLC SEPARATION OF PENTAVALENT ISOMERIC TECHNETIUM- 
99m-COMPLEXES OF DIMERCAPTOSUCCINIC ACID AND THEIR 
BEIWVIOUR UNDER VARIOUS CONDITIONS 
L. ~indemannl , C. ~chüttlerl , C. ~eumann2 ,R. ~ c h a e l 2 ,  S. Seifert, B. Johannsen 
l~undesgesundheitsamt, Institut für Sozialmedizin und Epidemiologie, B e r h  
2~edizinische Fakultät (Chariti) der Humboldt-Universität zu Berlin, Kiinik fur 
Nuklearmedizin 
Pentavalent technetium-99m-dimercaptosuccinic acid (~~~Tc(v)-DMsA) has become estab- 
lished as a new sensitive and specific radiopharmaceutical for imaging a number of tumours. It 
is used in particular for localization of metastases of medullary thyroid carcinomas [l-33. 
The mechanism of the Tc(V)-DMSA uptake in tumours has not yet been identified. The radio- 
pharmaceutical has been discussed as a metabolic mimic of phosphate [4J without knowledge 
of the structuire of the complex. Any rational explanation however requires a knom molecular 
structure as a prerequigte. 
Now it is known that the radiopharmaceutical contains technetium in the pentavalent state 
coordinated by 1,Zdithiolate ligands. The complex is ideritical with chemically characterized 
[ 9 9 ~ c ~ ( D ~ ~ ~ ) 2 ] -  showing a Square pyramidal codguration [5,6]. 
Carrier-added and also no-canier-added preparations consist of mixtures of tkee stereoiso~ 
mers [7]. AU three isomers are also significant components of the radiophmaceuticd, whiclb 
raises the question which of them are tumour-spccific 141. 
The isomers result fiom different orientationa of the carboxylate grougs in the 
as illustrated in Fig. 1. 
Preparation methods-: 
(1) Reduction with SnC12 (Radiopharmaceutical preparation) 
2ml of 9 9 m ~ c  pertechnetate saline and 0. lrnl of a solution of 7% NaHCO3 were added to a 
via1 of ROTOP-DMSA-kit for renal imaging containing 1 .Omg of dimercaptosuccinic acid, 
0.42mg of stannous chloride dihydrate and 0. lmg of ascorbic acid. 
The alkaline solution (pH 9) was shaken and allowed to stand for 10 minutes. 
In analogous carrier added experiments an amount of OSpmol 9 9 ~ c  was also added. 
(2) Ligand exchange reaction with Na gluconate 
Up to 80pl of a solution of SnC12 (2mg/ml in 0. IN HCI) was gradually added to a solution 
containing 2nd 9 9 m ~ c  pertechnetate, 25 mg sodium sah of gluconic acid and, in case of 
carrier-added tests, OSpmol 9 9 ~ c .  
The quality of the Tc gluconate preparation was checked by thin layer chromatography 
(chromatographic method A). When Na gluconate was formed a solution of 50mg DMSA 
in lrnl physiological saline was added. 
(3) Ligand exchange reaction with [TcOClq]' 
A small amount (1-2mg) ofBuqN[TcOClq] dissolved in 0.5ml acetone was added to 0.5 
ml of a solution of 50mg DMSA in acetone. Tc-complex formation was completed within 
a few rninutes. 
The quality of preparations (1) and (2) was checked by thin-layer chromatography (chromato- 
graphic method B). A typical TLC-chromatogram is shown in Fig. 2. 
Samples of Tc(V)DMSA prepared in the three ways described were analyzed by HPLC. The 
gradient system used in this study [4] (chromatographic method C) separated all three isomers 
by baseline separation and made it possible for us to estimate their relative concentrationis. 
chromatographic methods: 
(A) Thin layer chromatography (TLC) on SILUFOL eluting with acetone for quality con- 
trol of 9 9 m ~ c  gluconate preparations. 
Revalues 0.0 Tc(V) gluconate 
0.95 - 1.0 TcO4- 
(B) Thin Iayer chromatography (TLC) on Silicagel60 (MERCK) for preparation control of 
DMSA complex, eluting with n-butanol/acetic acid/water (3/2/3) 
Rf values 0.00 - 0.35 Tc(IV)DMSA 
0.65 - 0,70 TcO4- 
The thin layer strips were scanned under a gamma well probe detector (Berthold), 
Fig. 2: TLC chromatogram of aTc(V)DMSA complex solution according to procedure (1) 
(C) High performance liquid chromatography (HPLC) 
Precolurnn: 3cm C1 8 on Nucleosil (Machery & Nagel). 
Column: 15cm PRP-1 (Hamilton) 
Eluent: A= 0.1% tduoroacetic acid in water 
B= 0.1% trifiuoroacetic acid in acetonitrife 
Rate of total flow: 2dmin 
Gradient: Omin B=O% 
lOmin B = 50% 
16min B = 50% 
20dn B = 0% (stop) 
created by S m m - p m p s  &C-6A] 
Detection: For no canier added experiments by gamma-radiation rnod  
gamnia weil probe detector If3erihold); for ~aniei: added %%ts by ti9ts 
detection at 420 nm (S SPD-6 
RT values fmin]: 0-9 - 1.0 ~ ~ 0 4 -  
4.8 - 5 2  i s o w  1 
6,l - 6 3  isomer U 
7.1 '7.2 isomer 
The portion of each isomer in the mixture depends on both the methods used and the condi- 
tions of storage. We studied the infiuence of pH-value and temperature on the ratio of the iso- 
mers. Tab. 1 shows the relative isomer distribution for the different preparation methods. 
Fig. 3: HPLC chromatograms of the 9 9 ~ 9 9 ~ ~ c ( ~ ) - m e s o - ~ ~ ~ ~  complex @H=9) 
a = W  detection ; b=gamma radiation monitoring 
Tab. 1: Relative isomer distribution for the three diierent preparation methods used 
In further experiments the infiuence of pH-value and ternperature on the isomer ratio was stu- 
died. 
To a usud radiophannaceutical preparation at pH=9, 0.1M HC1 was added up t o  pH-1. This 
acidic solution was analysed by HPLC immediately &er preparation and then at hourly 
intervals. The pattern changes with time. After 5h isomer 11 represents the major peak, as seen 
in Fig. 4 (I / I1 / I11 = 40 / 50 / 10%). There is no Eurther change after a period of 72 hours. 
Fig. 4: HPLC chromatograrns ofthe ~ ~ / ~ ~ ~ T C ( V ) - ~ ~ S ~ - D M L S A  complex sdution 5 hours 
after pH decrease at pH=l; a=UV detecticon; b=gamma radiation monitoring 
Temperature is another factor that couhj affect dktribution. ARer heating the preparaiion at 
85°C in a water bath for 45 rninutes isomer m was found to have hcreased @ / = 43 1 
22 1 35%) (Fig. 5).  However, &er 1 to 2 hours alt room temperatur~;, the original ratio (Tab. 
1) was detected. 
Another point of interest was the pe& allocation 5or the TC(V')DIZSA GO-X prepared ~ 6 t h  
racemic DMSA as the ligand. For this experiment a ligand exchange . f . e a ~ t h  
method 2) was carried out with 50mg rao. DMSA The result W ~ S  ~beGked by 
shows a chromatogram of the complex solution. In addition $0 tb k n o ~  km 
meso DMSA (peak 1: Rfi.99; peak 3: RT=6,21 and peak 5: Rfl.27fi 
other components, as expected, vk. at R~5.64, 6.68 and 11.00dn. The relative isomer 
concentrations are also given in F&. 6. 
Fig. 5: HPLC chromatograms of the 9 9 / 9 9 m ~ c ( V ) - m e s o - ~ ~ ~ ~  complex solution after 
heating at 85OC for 45min; a = W  detection; b=gamma radiation monitoring 
The Same chromatogram was obtained for a usual alkaline kit preparation with meso DMSA 
&er standing for 48 hours at room temperature. 
The behaviour of separated isomers was studied in the following way: 
Typicd akaline complex solution was separated by HPLC fLTV and gamma detection) and lml 
of each of the fiactionated co1um.n eltiates containing the separated isomers I, iI or 111 was 
used for the following stability tests. 
(a) 100~1 of individual isomer solution was reinjected into the HPLC system about 20 
minutes &er separation. 
(b) Part of the eluate was placed in a water bath (85°C) for 30 minutes, and then 100~1 of the 
treated solution was malyzed by HPLC. 
(G) 500~1  isomer soMon was evaporated to dryness in a water bath (85°C) under nitrogen 
for 10 minutes. The residue was dissolved in 150pI acetonitrile and lOOpl was injected 
inta the chromatographic system. 
Peak 1 
Peak 2 
Peak 3 
Peak 4 
Peak 5 
Peak 6 
Fig. 6: HPLC chromatogram (UV detection) of a Tc(V)-rac.-DMSA complex solution 
Tab. 2 shows the behaviour of the three isomers in these tests. It is evident, that the isolated 
isomers are stable for at least 30 minutes in the acidic solution. After heating or evaporation 
isomerization begins and the other two isomers are rebuilt (tests b and C). in different rates. 
The relative isomer concentrations siowly approach the known ratios indicated h Tab. 1. 
Tab.2: The stability of individual isomer solutions under various conditions 
(a): 20min, 25"C, pH 1; @): 30min, 8S°C, pH 1, (C): IOmin, 85"C, 
evaporation 
- Isomer 
III 100% 
( 48% 1 (40% 11, 12% m) I 70% I(15% II, 15% 
I I 
Fig. 7 clearly shows the behaviour of isomer II in these tests. S ida r  results were obtauied fw 
the two other isomers. 
Fig. 7: HPLC stability studies of isomer Ii kept at different conditions (W detection) 
(a): eluate reinjection, (b): after heating, (C): &er evaporation 
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10. RHENIUM(V) COMPLEXES WITH MESO AND RACEMIC DMSA 
PART I: PREPARATION AND IDENTIFICATION 
S. Seifert, F. Schneider, H.-J. Pietzsch, H. Spies, B. Johannsen 
Rhenium shows a close chemical similarity to technetium and is suitable for radiotherapy 
because of the B-emitting radionuclides 8 6 ~ e  (tl/2 = 90h, EB = 1. lMeV, = 137KeV) 
and lg8Re (t112 = 17h, EB = 2.1MeV). The y-emission associated with decay of Ig6Re is 
also useful in scintigraphy. 
The so-called pentavalent 186/188Re-meso-DMS~ proposed by Bisunadan et al. [I] repre- 
sents a potential therapeutic analogue to the pentavalent 99m~c-meso-DMSA, which 
recently emerged as a useful radiopharmaceutical for imaging a range of tumours at low 
accumulation in normal tissues (except kidney) [2,3,4). 
The chemic? identity of ~ ~ ~ T C ( V ) - ~ ~ S O - D M S A  obtained from commercial "kit" prepara- 
tions has recently been described in detail (Blower et al.) [5], and preparation of 
9 9 m ~ c ( ~ ) ~ ~ ~ ~  by aqueous alkaline reduction of pertechnetate in the presence of DMSA 
has been shown to actually result in the formation of the pcO@MSA)2]- complex, which 
contains the pc=0]3+ core. Because of the chemical similarity of the two elements, the 
chemical structure of 186/188~e(~)DM~A should be @eO@MSA)2]-. 
As found for technetium, rhenium complexes with meso and racemic DMSA result in three 
isomers each (Fig. 1). 
Fig. 1: A: Possible isomers of w(meso-DMSA);r1" 
B: Possible lsomers of ~eO(rac-f>MSA)~]- 
Because the orientation of the carboxyli~ acid substituents of the more interesting meso- 
DMSA complex is not yet clear, we sought to isolate and characterize the individual isomers 
by chernical methods. 
Preparation of the complexes 
For preparation of the Re(V)DMSA complexes we used direct reduction of perrhenate by 
SnC12 in DMSA solution [I] as well as ligand exchange reactions of Bu,@[ReOC14] or 
ReOC13(PPh3)2 with DMSA. 
Reduction of perrhenate by SnCl2 
For preparation of Re(V)DMSA complexes by reduction, stannous chloride (22mg, 
O.lmmo1) was added to a suspension of potassium perrhenate (20mg, 0.07mmol) and 
dimercaptosuccinic acid (27mg, 0.15mmol) in water (2.5ml) and heated under nitrogen in a 
boiling water bath for 30min. After cooling the capped via1 was opened and Ehe resulting 
suspension was filtered using a 0.2pm fdter. [BuqNIBr or [PhqAs]Cl was added to 
precipitate the complexes. 
Fractional crystallization of the [PhqAs] salt from acetone results in two fractions. The first 
fraction contains pure orange crystals of the isomer ii (see HPLC analysis). The second 
fraction, however, consists of a mixture of a i l  three possible isomers of the Re(V)DMSA 
complex. 
Anal. calc. for PhqAslReO(DMSA)2] X 2 acetone (first fraction) 
C38Hqo011S4ReAs: C: 43.14%; H: 3.78%; S: 12.11% 
Found: C: 43.07%; H: 3.80%; S: 12.12%. 
It is also possible to obtain crystals of K@eO@MSA)2] by concentrating the original 
complex solution using a rotary evaporator. The red needles contain only the isomer 11, but 
they are not suitable for X-ray analysis. 
Anal. calc. for K[ReO@MSA)2]: 
C8H12011S4ReK: C: 15.07%, H: 1.88%, S: 20.09%. 
Found: C: 15.33%, H: 1.72%, S: 20.15% 
The potassium salt is readily soluble in water but only slightly soluble in other polar 
solvents like acetonihule, methanol, ethanol or acetone. 
After adding I]PhqAsJGl to the potassium salt and recrystallization from acetone, well-for- 
med crystals suitable for X-ray studies were obtained. 
IR-analysis: 3450, 1725, 1700, 2685, 1680, 1660, 1650, 1635, 1435, 960 (Re=O), 740, 
680,455crn-1 
Ligand exchange reaction 
Ligand substitution reactions were carried out with DMSA (lOmg, 0.05mmol) dissolved by 
heating in lml ethanol and dropwise addition of Bu4N[ReOC14] (lOmg, 0.017mmol) or 
ReOC13(PPh3)2 (lOmg, 0.012mmol) dissolved in lml ethanol or acetone. After stirring the 
mixture for 10 min the yellow solution was filtered and the isomer ratio was analyzed. 
For chemical identification of the complex solutions HPLC and IH NMR methods were 
used. 
The IH NMR analyses were carried out in D20 or acetone-d6 solutions using a Bruker AM 
250 system at a IH frequency of 250MHz. 
For HPLC analyses a PRP-1 column (Hamilton, 150 X 4.lmm) was used in conjunction 
with a linear gradient system of 0.1 % trifluoroacetic acid in water 1 0.1 % trifluoroacetic 
acid in acetonitrile. The effluent from the column (flow rate 2mlimin) was monitored by 
UV absorbance at 340nm. 
Results and discussion 
We studied the heterogeneity of the complex formation with meso DMSA as well as the 
racemic form of DMSA. 
Fig. 2 shows HPLC separation of the various Re-DMSA complexes prepared by stannous 
reduction of perrhenate in acidic aqueous solution. 
For the preparation of Re-meso-DMSA the three peaks are considered to the three possible 
isomers in accordance with results obtained with Tc-meso-DMSA [5]. With racemic DMSA 
containing meso DMSA as an impurity, there are two additional peaks at 4.6 and 7.0 
minutes, compared to meso DMSA on its own. 
On the basis of HPLC and 1~ NMR studies of the complex solutions, this complex can be 
assigned to isomers I, I1 and In. 
In acidic aqueous solution (Sn-reduction) a stable average isomer distribution of about 35 
I, 60% 11. and 5% III is found. 
A similar result was obtained by 1 8  NMR measurements of this solution, Fig. 3 shows the 
expected spectrurn of two singlets and one dublet with a 1:1 integral mtio caused by the 
three isomers of tbe Re-meso-DMSA complex. 
Further investigations concentrated on Re-meso-DMSA wmplexes because of the higher 
biological relevante of these compunds. An unexpected isomerization of the ~omplexes 
was found as descdbed in part Ii of this Paper. 
meso 
4L 0 
Fig. 2: HPLC separation of Re-complexes with meso and racemic DMSA 
(Sn-reduction method) 
HPLC analysis of the aqueous solution of the red needles results in only one peak at 5. lmin 
corresponding to the isomer II of the three possible [ReO(meso-DMSA)dm isomers. 
1~ NMR studies of this compound made in D20 showed that the isomer ii represents in 
fact a syn configuration of the carboxyiic groups of the tw6 meso-DMSA ligand molecules 
(Fig. 41, 
The symmefdc isomer II is dominant in acidic solution, followed by isomer I. The analysis 
of the spectmm revds that the sum of the two singlets of 1:l integral ratio corre- 
sponds to the yield of isomer I. That rneans that isomer I in HPLC represents the anti confi- 
guration of the carboxylic groups of the two meso-DMSA iigand molecules. 
Identification Of the other two shigfefs (syn-end0 md syn-exu - peaks II and III in HPLC) 
requires crystallogmphic confmation 161. X-ray analysis of the isolated tetra- 
snfurn sdt of isomer B is in progras. 
? ' , . j I l '  
4.40 4 3 0  4 3 0  ppm 
Fig.3: IH NMR spectrum of C-H proton region (4.2-4.6ppm) of [ReO(DMSA)2]- in D20 
The three stereoisorners were also obtained by ligand exchange reaction with DMSA dime- 
thylester or DMSA diethylester starting from Bu4NpeOCl4'J. WPLC analysis of the 
isolated DMSA dirnethylester complex, obtained after crystallization by adding methanol 
and redissolved in acetone, shows one dominant isomer @eak I) and smaller yields of I1 and 
111. The chelate ring Proton resonances observed in 1~ NMR analysis indicate that the 
dominant isomer is in the anti configuration Fig. 5). 
As expected, the elution order from the HPLC column is the Same for the isomers sf the 
<e(V)DMSA complexes as for the Re(V)DMSA diester complexes. 
* 
Fig. 5: HPLC and NMR analyses of Bu4NW(DMSA dimethy1ester)fj dissolved in 
acetone (dg) 
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11. RHENIUM(V) COMPLEXES WITH MESO AND RACEMIC DMSA 
PART 11: ISOMERIZATION EFFECTS 
S. Seifert, F. Schneider, M. ~indeisenl, H.-J. Pietzsch, H. Spies, B. Johannsen 
Institut für Oberflächenmodifuiening Leipzig 
Rhenium(V) and technetium(V) form three stereoisomeric complex compounds with meso 
dimercaptosuccinic acid as ligands. They are separable by HPLC and, in part, by chemical 
methods. 
The isomers marked I, 11, I11 are assigned to the anti, syn-end0 and syn-exo forms accor- 
ding to the results described in part I. 
The distribution pattem of the individual isomers depends on various parameters 111. The 
studies revealed unexpected isomerization of the complexes. There are remarkable differen- 
Ces concerning the effect of solvent and time on distribution patterns. 
In acidic aqueous solution (Sn-reduction) a stable average isomer distribution of about 35 % 
I, 60% 11, and 5% 111 is found, whereas in methanoiic, ethanolic or acetonic solution 
(ligand exchange) the initial isomer ratio is about 55 % I, 27% 11, and 18 % III. 
There are remarkable differences concerning the effect of solvent and time on the distribu- 
tion patterns. 
In acidic aqueous solution the isomer ratio does not change for weeks. In methanolic or 
ethanolic solution it changes after only a few hours (Fig. 3, but not so in acetonic or ace- 
tonitrilic solution, where it remains stable for some days at least. 
In further studies, the isomer rnixture as obtained in acetonic solution with the order of 
Portion I > 11 > 111 was evaporated to dryness and redissolved in water @H 2). As a result 
the isomer ratio changed to I1 > I > EI, thus indicating the possibility of a conversion of 
isomers. 
To find out whether the pH of the aqueous solution has any influence On the distribution 
pattems, the acidic solution of the complexes (35% I, 60% 11, 5% III) was neutralized. 
This resulted in a slow change of the isomer ratio at room temperature. 
At about 100°C (boiling water bath) the reaction is completed after about three hours and 
has then an isomer distribution of 47% 1, 25% 11, and 28% iII. 
The change is reversible. 
Fig. 1 shows that isomer I1 decreases in neutral solution, while I and 111 increas-. After 
heating at pH 2, isomer 11 is rebuilt from lII and I. 
These results indicate a dependence of isomer distribution On the preparation conditions 
(aqueous or non aqueous) and the possibility of changing the isomer ratio by varying the 
pH-vdue of the solution. 
Fig. 1: HPLC chromatograms of [ReO@MSA)2]- showing the dependence 
of the isomer ratio in aqueous solution on pH value. 
The stabzty of the individual isolated isomers in solution differs. While isomers I and I11 
isomerize immediately after separation by HPLC, resulting in the typical isomer ratio U > 
I > m because of the acidic eluent, isomer Ii is stable at room temperature for 1' - 2 hours 
arid can be kept stable for longer in a frozen solution. 
Accordi@yy the aqueous solution of the crystaiiized isomer Ii (KPeO@MSA)21) with a 
resulting pH 2 is also stable for some hours. Isomerimtion at room temperature proceeds 
very ~ 1 0 ~ 1 ~  as Seen iri Figs. 2 and 3. 
After more than 100 hours the typid yields of all three isomers can be detected in the 
solution by MPLc arid 1~ NMR. 
The original solution shows ody one strong singlet at 4.39ppm in 1~ NMR analysis after 
about 15min. 
The yields of the o&er isomers (two singlets of 1:l integral ratio at 4.42 and 4.45ppm and a 
weak singlet at 4.47ppm) iecrease in time up to the equilibrium isomer ratio for an acidic 
A solution, 
Fig. 2: HPLC analysis of KpkO@MSA)2] (isomer 11) dissolved in water as a function of 
time after dissolution. A: 15min, B: 2.5h, C: 24h, D: 48h, E: 120h 
Fig. 3: IH NMR sp t ra  of C-H region (4.3-4.6ppm) of BeO(DMSA) 
tion of time after dissolution ui DzO; A; 15min, B: 2 3 ,  C: 
The isomer ratios measured at different times by 1~ NMR correspond very weil with those 
determined by HPLC analysis (Fig. 4). 
Fig. 4: Isomexkation of K ~ ~ o @ M s A ~ ~ ]  dissolved in water as a function of time 
mwured by HPLC and 1~ NMR studies 
At pH 7 isomerization takes 1-2 days at room temperature (Tab. 1). After acidification (pH 
2) about 20 hours are needed to restore the isomer pattern of an acidic solution of 
peO@MSA)a-. 
The reactions can be accelerated by heating. 
The above-mentioned change of the w@MSA)2]- complex solution in methanolic or 
ethanolic solution seems to be a gradual esterification of the Re-DMSA complex isomers. 
The products, observed in HPLC after more then 3 hours, with RT vaiues of between 6 and 
9 minutes are probably isomers of meso-DMSA half-ester complexes. 
Preparations of the DMSA monoester for the synthesis of the corresponding Re-complexes 
are in Progress. 
Tab. 1 : Isomerization of ßeO@MSA)s]- (11) in water at pH 7 and room temperature 
Fig. 5: HPLC chromatograms of complexes showing change of the 
isomers in m e t . 0 1  as a function of time after preparation, A: Smin, B: 3.5h, 
C: 24h, D: 6d, E: Re-meso-DMSA dimethylester 
t [h] 
0 
0.5 
2.5 
4.0 
22.0 
48.0 
Acidified to pH 2 
3.5 
19.0 
On the other hand, step-by-s&p hydralyzation of the DMSA diester complex in 
solution results either in 3aeemization (arnmonia, amines) or in eornpkite hy 
racemizarion into the fReQ(~~-DMSA)~f'coapfex isomers, as 
I 
1.1 
5.7 
26.4 
30.9 
51.0 
46.3 
34.5 
33.7 
I1 
98.9 
94.3 
65.5 
57.6 
35.3 
29 :2 
47.8 
57.5 
I11 [%] 
0 
0 
8.1 
11.5 
13.7 
24.5 
17.7 
8.8 
Fig.6: HPLC chromatograms of racemization (A) and hydrolyzation/racemization (B) of 
Bu4N[ReO@MSA dimethylester)2] by treating with ammonia (A) and heating 
with sodium hydroxide solution (B) 
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The 
TECHNETIUM AND RaENIUM TRACERS WITH METABOLIZABLE 
ESTER FUNCTIONS 
R. Syhre, S. Seifert, F. Schneider, H.-J.Pietzsch, H. Spies, B. Johannsen 
introduction of ester groups into appropriate moieties of technetium and rhenium 
complexes is considered a promising approach to Tc/Re tracers which should be trapped in 
viv0 in the target Organ. Built-in ester bonds also may help to improve targetlnontarget ratios 
due to faster excretion of background radioactivity when enzyrnatic cleavage takes place in the 
blood. Cheesman et al. [l] succeeded in developing a brain pefision imaging agent with ester 
derived diamine-dithiol ligand, which undergoes enzymatic hydrolyses in the brain. The 
technetium complex of N,N'-1,2-ethylenediyl-bis-L-cysteine diethyl ester, ECD, shows 
excellent uptake and retention characteristics. 
We synthesized a number of technetium and rhenium complexes with sulphur donor ligands 
possessing metabolizable ester iunctions. Most of them belong to the class of 
oxotechnetium(V) complexes and involve both anionic complexes (I) derived fiom bi or 
tetradentate ligands and neutral complexes (11) with tridentate/mnodentate coordination. In a 
first series all these compounds were functionalized so that the complex unit was bound to the 
carboxylic site of the ester group. Preparation of correspondiig compounds with an inverse 
arrangement of the carboxylic and alcoholic parts is in Progress. 
M = Tc, Re 
R = Me, Et 
Preliminary investigations on enzymatic hydrolysis of the ester group in anionic 
oxotechnetium(V) complexes were c&ed out with methyl zuid ethyl esters of meso-2,3- 
dimercaptosuccinic acid as ligands (I). 
The Re-DMSA ester complexes were prepared by Iigand ex~change seartion starting with 
F'hqAs[ReOC&]. ARer dissolving acetone a slight excess ofthe desired DMSA ester 
was added and the solution was allowed to stand for some minutes. 
the compounds crystallize and can be isolated. 
To detenrtine whether tbe ester bond in R-e-D&&4 ester complexes 3s susceptible to cieavage 
by esterases, initubagon experiments wlth tissue hom &es amd p k m a  were  mied out. 
Experiments 
6-7mg of the complex compound was dissolved in lrnl ethanovwater (50/50). 
Generally, O.1ml of the complex solution (6-9x10-3mo~l) was added to 0 . 9 d  of the esterase 
containing samples. 
For incubation experiments homogenates from the liver, lungs and brain of rats, diluted 1 :20 
with phosphate buffer of pH 7.4, as well as blood plasma of rats and hurnans, diluted 1:l with 
phosphate buffer of pH 7.4, and phosphate buffer only, for reference, were used. 
The incubation of complexes took place at 37OC for 60 minutes. After incubation the samples 
were centnfuged and analyzed by HPLC. 
For HPLC analyses the System for separation of Re-DMSA complexes as deseribed in [2] was 
used. 
Results and discussion 
Fig. 1 shows chromatograms of Re-DMSA diethylester and diethylester complex solutions 
&er dilution with phosphate buffer as a reference for the esterase-containing samples (Figs. 2 
and 3). 
Fig. 1: HPLC chromatograuns of ßeO@MSA dimethy1e~ter)~l- (A) 
and [ReOPMSA diethyle~ter)~]- @) after incubation in 
phosphate buffer ($3 7.4,37OC, 60min.) 
A csmplete separation of the three stereoisomers of the diester complexes was not possible 
systern used. The analysis showed one peak of 10.0 for the dimethylester 
complex and two peaks of 12.2 and 12,7 for the diethylester complex. 
Both complex compounds do not change significantly in buffer solution, but variations were 
observed in esterase containing samples of rats. 
According to the HPLC chromatograms the enzymatic effect is qualitatively similar in blood 
plasma, h e r ,  lungs and brain. 
About 80% of Re-DMSA dimethylester was changed in blood plasma and liver homogenate 
and about 50% in lung homogenate (Fig. 2). 
Fig. 2: HPLC chromatograms of [.eO@MSA dimethyle~ter)~]- &er incubation in 
plasma(A),and homogenates of liver P), lungs (C) and brain (D) of rats, 
(phosphate buffer pH 7.4,37OC, 6Omin) 
After incubation of Re-DMSA diethylester in plasma and liver homogenates, about 50% of the 
complex was changed (Fig. 3). 
However, only low variations of <10% of both anionic complexes were found in brain 
homogenates of rats, 
The enzymes, responsible for cleavage of the tracers, and the nature of the metabolites still 
have to be identified. 
Fig. 3: HPLC chromatograms of [ReO@MSA diethyle~ter)~]- after incubation in 
pIasma(A),and homogenates of h e r  (B), lungs (C) and brain (D) of rats, 
(phosphate buffer pH 7.4,37"CY 60rnin) 
Prelirninary results suggest that the ester cleavage proceeds gradualiy up to the monoester 
complex. The Re-DMSA monoethylester complex prepared by ligand exchange reaction of 
FeOCIql- shows RT values of 8.2,8.4 and 9.0 in HPLC. These RT vaiues are also observed 
in incubation studies (Figs. 3 and 4) in addition to RT values of 10.2 and 10.8 possibly arising 
from cleavage of only one ester group of the complex compound. 
Apart from the possible monoester complexes (RT 8.4 and 9.0), the incubated solutions of the 
Re-DMSA dunethylester complex aiready contain smali amounts of the completely hydrolyzed 
O@MSA)s]- showing the known RT values between 4.6 and 6.2 121. 
hterestin@yJ this studies aiso indicate that the metabolization behaviour of diester complexes 
might be dependent on species. Whiie in rat plasma 50-80% of the Re-DMSA diester 
complexes are metaboiized, in human plasma ody the blank value is found @ig. 4). 
CIeavage of f he DMSA 
is also influenced bq. stereo-specifk factors. As shown in Fig. 3, the isomer with RT 12.2 is 
metaboked, white that with RT 12.7 is not changed signifi~antl~. 
Fig. 4: HPLC chromatograms of peO@MSA dimethylester)2]- (&B) and weO@MSA 
diethylester)$ (C,D) after incubation in rat plasma (&C), and human plasma @,D), 
bhosphate buffei pH 7.4,370C2 60min) 
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13. TECHNETIUM COMPLEXES WITH THIOETHER LIGANDS 
2. SyNTHESIS AND STRUCTURAL CHARACTERIZATION OE" NEU- 
TRAL OXOTECHNETIUM(V) COMPLEXES WITH DITHIOETHERS 
H.-J. Pietzsch, H. Spies, P. kibnitzl, G. ~ e c k l ,  J. ~ e ~ e r 2 ,  R. ~ a c o b i ~  
l~undesanstalt für Materialforschung, D-1199 Berlin 
2~er~akademie Freiberg, D-9200 Freiberg, 
Neutral, bidentate thioethers such as 5,8-dithiadodecane, 3,6-dithiaoctane (" S2") as well as 
the dithia-diol 1,8-dihydroxy-3,6-dithiaoctane ("S2(0H)2") react with tetrachlorooxotechne- 
tate (TcOCl4) in acetone to form binuclear 0x0 species of the type ~ c O ( " S ~ " ) C 1 ~ ] ~ 0  with 
dithiaalkanes and ~cO("S~0(0H)")Cl~] with the dithia-diole, respectively. The complexes 
have been characterized by elemental analysis and spectroscopic methods. 
The crystai structures of w(5,8-dithiadodecane)C12]20 (1) and [Tc0(8-hydroxy-3,6- 
dithiaoctan-1-olato)C12] Q) were determined from X-ray data [I]. 
Recently we found that cationic Tc(lII) complexes containing neutral tetradentate thioethers 
and monothioles as co-ligands are forrned when an appropriate technetium precursor is re- 
du& by stannous chloride in the presence of both a tetrathiaalkane and a monothiole [2]. 
As observed earlier 133, reaction of pertechnetate with two equivalents of stannous chloride 
in the presence of e.g. R-S-CH2CH2-S-R ("S2", R=alkyl) in acetone or acetic acid yields 
yellow-green coloured products. These species are reactive in ligand exchange reactions 
with e.g. 2,3-dimercaptosuccinic acid dimethylester, resulting in formation of the known 
bis(dithiolat~)oxotechnetate(v) complexes 143. We assume therefore our new species to be 
in the oxidation state +V. This prompted us to attempt the isolation and characterization of 
definite Tcw) complexes with dithiaalkanes and related compounds. Preparation of new 
definite Tcw) complexes was successful with tetrachlorooxotechnetate(V) as a precursor, 
not with the less reactive Tc(V) gluconate. 
Dithiaalkanes as well as the potentially tetradentate 1,8-dihydroxydithiaoctane react with 
TeOCl4- under partial exchange of chloride ligands by S atoms of dithia ligands. 
3,6-dithiaoctane (R=C2Ij[5) and 5,8-dithiadodecane (R =CqHg) produce in aceto- 
nehethanol analyIJ-dy pure yellow-green 0x0 complexes of the frcO("S2")Clsj20 type, 
whlch precipitate h m  the reaetion mixtures. 
The neutral complexes are stable on exposure to air and, except for acetone and acetonitrile 
insoluble in the common organic solvents. Elemental analyses are consistent with the propo- 
sed formulations (Tab. 1). 
In the infrared spectra strong absorptions at 920cm-1 for 0, Q) as well as for indicate 
the T C = O ~ +  core; v(Tc-Cl) is not assigned owing to the absorption of other vibrations in 
the region 300-250cm-1. 
Tab. 1: Yields and analytical data of the complexes 
In order to obtain an unambiguous structural assignment, the structures of the complexes (1) 
and @ were determined by X-ray structure analyses. Suitable crystals were obtaincrd from 
acetonelmethanol. Drawings of are shown in Figs. 1 and 2 and of (3") in Fig. 3. Selected 
bond angles and distances are listed in Tabs. 2 and 3. 
In both complexes flip-flop mechanisrns are observed in the ring Tc2, S4, C3, C4, S3 
(complex U) and TC, SI, ~ 3 ,  ~ 4 ,  ~2 {complex B]. This causes smearing of the electron 
density of the C4 atoms of both molecules, 
The crystal structure of U consists of two independent TcO("S ")Cl2 units brid 
oxygen atom. 
The characteristic feature is the presence of the O=Tc-0-Te=O mup. In this r e s ~  
stnicture of is cornparable to tbse  of frcO(d@)]20 (s.pd = N,NLpropane-1,3-diy1- 
Yield 
(%) 
Elemental analysis (Calc. Ifound ( 
C S H C1 
bis-(salicylideneiminate) [5], and frcO(N2S2)]20 (N2S2 = N,N' -ethylene-bis(thio- 
acetylacetone-iminate) [6] 
The technetium atoms are centreü in a flattened octahedron with the equatorial plane form& 
by a S2Cl2 donor set, in which the technetium atoms Tc1 and Tc2 are 0.12A out of plane 
towards 0 1  and 02  respectively. The SsCI;! planes are ahost parallel with a small deviat- 
ion 0f 0.013A; the dihedoil angle is 2.6". The sulphur and chlorine donor atoms of the 
are in the anti-position with respect to the bridging oxygen. 
The bond lengths of the Tc=O cores with 1.665 and 1.674A respectively, are in the rmge 
generally found for these units (1.61- 1.75A), but they are in between those in the octahe- 
&al O=Tc=O compounds and in square-pyramidal Tc=O complexes. This coflesponds to 
the relativei~ low value of Tc=O absorption in the infrared spectrum. 
'rh" bndging Tc-0 
the average Tc=O length and the average Tc-0 bond distartce whicfi Z e  o b s e d  
in the range 1.98- 
Fig . 2: Molecular geometry of ~c0(5,8-dithiadodecane)2C1~2@iewed perpendicular 
(on the left) and parallel to the 01, Tc1 , 03,  Tc2, 0 2  axis 
As illustrated in Fig. 3, complex @ consists of discrete monomolecular units coniaining the 
0 =Tc-O- core. 
Tab. 2: Bond lengths (A) and angles (deg) for ~c0(5,8-dithiadodecane)2C12]20 
In general, the stnicture strongly resembles that of the complex derived from dithiaoctane. 
mwever, while in the dinuclear sgecies the trans-position is occupied by a bridging oxygen 
which may come fiom traces of water present in the reaction mix-ture, the trans position in 
complex 1(" is mxupied by an oxygen of one of the tennind hydroxy groups. The second 
hydroxy group remains "free". "ie CEELGRAF [I01 drawing in Fig. 3 shows the two 
psssible positions for the noncoordinated hydroxy group caused by a rotation disorder about 
the bond C5, Cd. The S atoms of the er and the two C1 atoms which remain at the 
metal due to the inco exchange at the tetrachlorooxotechtietium ion fom a cis-man- 
gernent in the equato~d plane. 
s witb a single bondd oxygen trans to the Tc=O core have been hardly 
described sa f'ar. 
The kngtb of the Tc-0 bo~d  (1, le to that fomd in other bms-O=Tc-0- 
70 
Tab. 3: Bond lengths (A) and angles (deg) for pcO(8-hydroxy-3,6-dithiaoctan- 1 - 
olato-(0,s ,S))Cl2] 
This new dass of technetium complexes is worthy of special interest as manifolde subse- 
quent reactions can be anticipated. Diversity is given in ligand exchange reactions by vaiQus 
leaving groups in the coordinatiort sphere. For complex @ additional reactivity may be 
caused by the noncoordinated hydroxy group at the side chain. New mdiopharmacoiogidy 
relevant compounds may thus become acwsible. Studies on the reactivity ~f the des~fibed 
complexes will follow. 
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14. TECHNETIUM COMPLEXES WITH THIOETHER LIGANDS: 
3. SYNTHESIS AND ST&JCTURAL CHARACTERIZATION OF 
CATIONIC TECHNETIUM COMPLEXES WITH THIACROWN 
ETHERS 
H.J. Pietzsch, H. Spies, P. ~eibnitzl, G. ~ e c k l  
l~undesanstalt für Materialforschung, D-1 199 Berlin, 
As part of our programme of studying the Tclthioether chemistry and checking the suita- 
biltity of the resulting compounds for radiopharmacological purposes, we studied the 
capability of the TcN-core of being coordinated by thioether groups. The TcN-core shows a 
great capacity for stabilizing the meta1 in high oxidation states 11-31. By now TcN comple- 
xes of the tetraaza macrocycles 1,4,8,11-tetraazacyclotetradecane (cyclam) 143, 1,4,8,11 
tetraazacyclotetra-decane-5,7-dione [5] and the analogous azalthia ligand 1,4-diaza-8,ll- 
dithiacyclotetra-decane [6] have been fully characterized. 
In Order to gain an insight into the effects on cmrdination geometry and complex stabilities 
of factors such as ring size and functional group substituent in macrocycfic po1ythioether li- 
gands we synthesized a number of technetium chelates with the thiacrown ethers 1,4,8,11- 
tetrathiacyclotetradecane (14S4), 1,5,9,13-tetrathiacyclohexadecane (16S4), 1,5,9,13-te- 
trathia-cyclohexadecane-3,ll-diol (16S4-(OH12) and 1,4,7,10,13,16-hexathiacycli~octa- 
decane (18S6). Some representatives were characterized by X-ray crystaJ. structure detemi- 
nation. 
The ligand exchange reactions on NBu~VCNC~] proceeding in acetonehnethanol solutions 
at arnbient temperature result in the formation of cationic complexes ITCNC~(S~)~+. 
The crystalline compounds precipitate from the reaction mixtures in andytically pur@ form. 
The elemental analyses correspond to the formulations [TcNC1(§4)JTcNC14 for 14S4 i& 
16S4 1(21 and 18S6 B, p'cNCl(S4)]3Ph4 @ and r]rcNCl(l6S4-(0H)2)]Cl B (see Tab, 1). 
From a mechanisti~ geht of vim It 3s hteresting to note that .the co 
This may be explained by the faet that the exchange reaction is coupled with a reduction of 
Tc(VI) to Tc(V), and methanol is assumed to be the reducing agent. 
Tab. I: Yields and anaiytical data of the complexes m-a 
Elemental analysisa 
C H N S Cl Tc 
aCalc./found 
The exchange rate for the ligands 14S4, 16S4 and 18S6 is about 50%. The complex cations 
obviously formed combine with the precursor to produce only slightly soluble salt, thus 
further exchange. The reaction is practically quantitative in the presence of al- 
ternative counterions (e.g. BPh4-, PF6-1. 
tim that &e solubility of the formed complexes in the xeaction media governs 
the reacticm route is supporteü by the reaction of 16S4-(OH)2. The exchange reaction with 
tfüs Egmd, w k h  bears two OB groups, is practicaliy quantitative in the absence of addi- 
tional countenons. 
of all complexes without alternative counterions i11431 are cha- 
band of the TcNC14- moiety (Lmax: 404nm, 460nm (sh) in 
acetone/metfranol). 
S ~ O W  l a s  chmct&stic bands in the r a g e  between 1000 and 1 1 0 0 ~ ~  
which we assigne to the TcN core of &e compiex cations and additional peaks at 1080cm- 
fix compunds (11, (2) and (3) which contain the TcNC14- &n. 
74 
Structure of lTcNCl(14S4)]TcNC14 and ~cNCZ(18S6)]TcNCZ~ 
The molecular stnictures of compounds I11 and together with the atornic numbering 
schemes are given in Figs. 1 and 2. Selected interatornic distances and angles are sum- 
marized in Tabs. 2 and 3. 
fLLand B consist of couples of independent cations with the meta1 in the oxidation state 
+5 and hexavalent TcNC14- anions. In both complex cations the Tc atom is six-coordinated 
in a rather distorted octahedral geometry, being directly bound to four sulphur atoms of the 
macrocyclic ligand .in the equatorial plane. The nitrido and the chlorine atoms occupy the 
axial positions. 
Fig. 1: CELLGRAF drawing of ~cNC1(14S4)]TcNC14 
Tab. 2: Selected Bond lengths (A) and angles (deg) for [TcNC1(14S4)]TcNC14 
le fhe molecular cation U has a noncrystallographic mirror plane through Tc(l), N(l), 
Cl(l), C@), C(% a mirror plane through Tc(l), N(l), Cl(1) , S(5), and (S6) does not exist 
noncrystailographic syrnrnetry was disturbed by a dislocation of the atoms C(5) 
and C(6) caused by packing of the molecules in the unit cell. 
The Tc: atom is displacd from the plane formed by the four S atoms by 0.236A toward the 
N(]I) atoni ccqmmd U and by 0.209A in compound B. The Tc(l)=N bond distances 
of 1.615A fm i.l.l and 1.707A for j.3 are consistent with the tnplle-bond distances found in 
irttldo eomplexes srfsucturaliy chmcterized [7]. 
resembfles that of the ~CNCI(N~) ]  cations (N4 = 2 en, 
Fig. 2: CELLGRAF drawing of the molecular cation of ~cNC1(18S6)]T~NC14 
Stmcture of flcNCZ(16S4-(OH)$3 & 
The octahedral molecular structure of is comparable to that of ~ c ~ ~ l ( 1 4 ~ 4 ) ] + :  four S 
atoms of the thiacrown ether form the equatoriiil plane, the nitrido and Cl- iigands are in the 
axial positions (Fig. 3, Tab. 4). The metal is displaced froin the equatodal piane by 0.114A 
toward the N atom. As found for the complex cation has a noncrystallographic mh0r 
plane through Tc, N, C1(1), C(2), 0(2), C@), O(1). 
In the crystal the cations and the Cl- counterions aze connected by fvvo symmetry-indepen- 
dent hydrogen bonds O(1)-H---Cl(2) (3.045A) and C!@)---H-0(2)'(2.9734 forrnhg ~hains 
in [I 1 01 direction. 
FcNC1(16S4-(0H)i]Cl deviates f romm and conceniiag the extremely 10% 3k-N 
bond distance. 
Tab 3: Selected Bond lengths (A) and angles (deg) for ~cNC1(18S6)]TcNC14 
For all three compounds studied by X-ray analysis, coordination of technetium by four 
sdphur atoms in the equatorial plane was found to be the common feature regardless of 
differentes in ring size or the presence of two additional sulphur atoms in the ring of 18S6 
or two hydroxy groups in 16S4-(OH)2. 
etry of the distorted octahedral TcN complexes having a sixth, negatively charged 
ligand in trans position to the TcN bond may be explained in terms of balancing the strong 
influence of the nitrido group, which destabilizes the octahedral coordination, and by the 
emand for an effective neutralization of the residual charge on the T C N ~ +  group [9]. 
The &ans hfiuence: of the nitrido ligand is, for example apparent in pcNC12(PMe2Ph)3] in 
the G ~ S  and trans Tc-C1 bond lengths of 2,441 and 2.665A, respectively . 
Fig . 3: CELLGRAF drawing of the molecular cation of [TcNCl(16S4-(OH)2)]Cl 
Tab. 4: Selected bond lengths (A) and angles (dei) for ~cNCl(16S4-(OH)2)]Cl B 
As shown in Tab. 5 for previously described compfexes as 
here, both the TC-N anrt Tc-Cl bond 1mgths vary over a vvjde 
the congener xhenium. 
Tab. 5: Bond lengths of Tc/Re nitrido complexes with trans-coordinated C1 
complex 
Abbreviations: 
bond length [Al 
Me=N Me-C1 
1.603 2.732 
1.626 2.663 
1.624 2.665 
1.854 2.608 
1.615 2.718 
1.707 2.567 
1.950 2.469 
1.660 2.633 
1.788 2.563 
1.839 2.451 
Ref. 
14 
14 
15 
17 
this paper 
this paper 
this paper 
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20 
2 1 
en: ethylenediamine . 
tad: 1,5,8,12-tetraazadodecane 
dpae: 1,2-bis(dipheny1arsino)ethane 
dmpe: 1,2-bis(dimethy1phosphino)ethane 
ConsidePable Tc-N bond lengthening was found for ~ c ~ ( d m ~ e ) s ~ l ] +  (dmpe = dimethyl- 
phosphinoethane; Tc-N bond distance: 1.85A) /10,11/ and attributed to steric interactions 
between the nitrido group and the CO-planar phosphorus atoms [12]. 
e the Tc-N bond lengths of (f) and B fall in the range between about 1.60 to 1.854A, 
the distance of 1.9SOA observed in the preliminary X-ray structural analysis of 
~ c ~ l 6 S 4 - f s H ) ~ C l  is exceptionally long. 
Mar~hi et al. [a have already pointed out that the lengths of the TcN and Tc-C1 bonds are 
inverseIy related. On the one hand, the strong trans influence of the nitrido ligand in 
(eo)d+ causes a considerable lengthening of the Tc-CI distance at 2.732A, 
e longest Tc-CI bond distance ever observed in Tc complexes the other, the ex- 
distance in FcNCl(1 ~s~-(oH)~)]+ anied by a 
to a distance normally found for equatoridly bound chlorule 
(2.49A). 
s is also tnile of the TcN compIexes contained in Tab. 5. The Sums of the appropriate 
bond leagtfts are relatiuely constant. 
naay be indicative of a tendency to adopt a Iess distorted 
technetium is closer to tke plane (0,1 l4A) than kund 
80 
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15. TECHNETIUM COMPLEXES WITH THIOETHER LIGANDS: 
4. CATIONIC T c 0  COMPLEXES WITH TETRADENTATE THIO- 
ETHERS AND MONODENTATE THIOLS: PREPARATION AND 
PRELIMINARY BTOLOGICAL EVALUATION 
H.J. Pietzsch, S. Seifert, R. Syhre, H. Spies 
Recently we found that cationic Tc(III) complexes, ~C("S~") (SR)~]+ ,  are formed when 
pertechnetate is reduced by stannous chloride in the presence of both a tetrathiaalkane and a 
monothiol [I]: 
~ n 2 +  
+ “S411/RSH ....................... > ~c("s~") ( sR)~]  + 
"S4": R '-CH~CH~-(S-CH~CH~-S-CH~CH~)~-R ' (n =2; R ' =H, ethyl) 
RSH.: R=alkyl, aryl 
The lipophilic compounds are extractable from the reaction mixtures by chloroform and can 
be isolated as P &  sdts. 
The complexes are interesting as potential myocardium affine agents with their positive 
charge and in analogy to cationic diphosphinelthiolate Tc@) complexes [2]. 
In this paper we are reporting on the preparation of the cationic species at carrier-added 
level and on the preliminary evaluation of their biobehaviour in the rat. 
iribution studies the complexes (see Tab. 1) were prepared with 10-~rnol/l 
9 9 ~ ~ 0 ~ -  in aqumus-acetonic solution according the following standard procedure: 
0.5mg of the tettatbiaalkane and 2.5mg of the thiol were dissolved in 1.5ml acetone. This 
mixture was added to a solution of 20mg mannitol in 0.5ml 99199rn~c-pertechnetate (10-~ 
mofflf. After addition of 2.Omg SnCl2 in 0. 1ml ethanol the reaction mixture was allowed to 
olutions acetone was evaprated under &trogen, the residues were di- 
saline and filtered tbough a 0.2pm filter. 
fomed were characterized by HPLG (L 18, TP7if</OSrn 
gel, metdianaI/THF/O.Sm NH4OAc (50/5/40)). A typical pro- 
in Fig. 1, 
Tab. 1: Tc complexes for in-viv0 studies 
At lower Tc concentrations the yield of the desired product decreases and becomes < 18% 
at n.c.a. level. It was found that the RT values of the cationic complexes correlate with the 
partition coefficients in octanol/saline (see Tab. 2). 
Fig. 1: HPLC product distnbution Pattern of a preparatirtn of complex (3) at taifferene TC- 
concentrations (yields in %) [a: o ~ ,  = 2~10-4~(80-90); b: qc = 2 x 1 0 ' ~ ~  3 
Tab. 2: Correlation of the RT-values of complexes (I), (2) and (3) with their lipophilicity 
complex Rt(min) lg p.c. 
(octanol/saline) 
(1) 5 1.4 
(2) 7 2.1 
(3) 10 3.6 
Biological evaluation 
Animal studies were performed on male Wistar rats (150g BW) after intravenous admini- 
stration of the 99/99m~c-compounds. The animals were killed at intervals ranging from 5 
minutes to 2 hours after the injection 
All complexes studied show similar biodistribution pattems with significant myocardial 
uptake. This uptake is most pronounced with the complexes (2) and (5). Blood elimination 
is. faster than the myocardial washout (see Fig . 2). 
'Be lipophilic nature of the complexes causes a high hepatobiliary uptake and excretion (50- 
70% dose p-L). as shown in Fig. 3. 
Fig, 2: 33kod e1iniuration and myocardiaf washout of complexes 
(I), (21, (3) and (5) in % dosefgram 
% DOSE 
Fig . 3: Hepatobiliary pool of complexes (I), (2), (3) and (5) in % dose 
The myocardium affinity of the new lipophilic and positively charged complexes is not 
surpnsing in view of their analogy to the well-known diphosphine/thiolato compounds 111.. 
In contrast to them, thioether complexes appear to be less susceptible io reduction in vivs, 
As such susceptibility is blaimed for undesired washout from the myocarcfium [23, thioether 
~complexes may be advantageous. Until now, their prepaation is restricted the d e r - a d -  
ded level. To overcome this obstacle, we will focus our investigations on l e s ~  s&rlr: con- 
strained bidentate thioethers R-S-CH2CH2-S-R. 
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16. SYNTHESIS AND CHAR4CTERIZATION OF NEUTRAL 
TECHNETIUM(III) COMPLEXES WITH THE TRIPODAL LIGAND 
TRIS(2-MERCAPT0ETHYL)AMlNE 
H. J. Pietzsch, H. Spies, F. E. ~ a h d  
l ~ r e i e  Universität Berlin, Institut für Anorganische Chemie 
The trianionic tetradentate ligand tris-(2-mercaptoethy1)-amin (NS3) reacts with 
TcC13(PPh3)2(CH3CN) in a 1: 1 ratio to produce neutral lipophilic Tc(1II) complexes. De- 
pending on the polarity of the solvent two different compounds were observed: 
In a polar mixture of methylene dichloridelmethanol (1:4) three chlorine and one phosphine 
li-gands are substituted, forming TcNS3(PPh3) (D. - In pure methylene dichloride both 
phosphines are retained and TcNS3(PPh3)2 (3 is formed. Complex (I) - is obtained in form 
of violett crystals (km: 541 nm), whereas complex (2) - is a blue powder (Xmm: 597 nm). 
Both compounds were characterized by elemental analysis, infra red, UVIvisible and NMR 
spectroscopy 
An X-ray single-crystal structure determination of TcNS3(PPh3) (I) - shows that the complex 
has a trigonal-bipyramidal geometry with the nitrogen and the phosl;horus in the axial posi- 
tions and the sulphurs bound in the equatorial plane (Fig. 1 and Tab. 1). 
In this respect the stnicture is comparable to that of Tc(P(o-C~H~S)~)(CNC~H~) [I]. A 
similar coordmation geometry is found in the neutral T c 0  complexes TcPR3(SXS)(SR), 
formed by rduction of the [3+ l~complexes TcO(SXS)(SR) with an excess of phosphine in 
acidc sohiion @=dkyl, aryl; SXS=tridentate ligand of the type HSCH2CH2-X- 
CE$H2SH, X=O, 
Owing to the reducing power of the phosphine and the thiol compound, (1) can also be pre- 
pared directly from prtechnetate with an excess of triphenylphosphine and tris-(2-mer- 
capmthy3)amine; in this reaction TcNS3(PPh3)2 (2) - was not be observed in significant 
This makes the procedure very easy and gives access to a new class of T C ~  + complexes for 
I radiopharmaceutical studies with Tc-99m at C. a. and n.c. a. level. 
Fig. 1: ORTEP-drawing of TcNS3(PPh3) 
Tab. 1. Bond lengths (A) arid angles (deg) for TcNS3(PPh3) (I) 
kferences 
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17. RHENIUM COMPLEXES WITH TRIPODAL TETRADENTATE 
LIGANDS CONTAINING SULPHUR DONORS 
H.-J. Pietzsch, M. Glaser , H. Spies, J. ~ e ~ e r l ,  R. ~acobil 
lBergakademie Freiberg , Institut für Organische Chemie 
Our studies of technetium and rhenium complexes with tripodal ligands are aimed at 
designing mixed ligand compounds M(XY3)Z where the monodentate CO-ligand Z may be 
stmcturally varied in a wide range and should be capable of being functionalized by reactive 
groups. So far, TcfRe complexes of tripodal ligands with oxygen [1], phosphonis [2], 
isonitrile [3] and sulphur donors [4] are known. 
After having synthesized Tc(NS3)PPh3 as a typical representative of the desired complex 
type, we are now investigating the formation of rhenium complexes with tris(2- 
mercaptoethy1)amine "NS3" and tris(3-mercaptopropy1)amine as tripodal ligands and 
triphenylphosphine as a monodentate CO-ligand. 
Ammonium perrhenate, trans-oxotri~hlorobis(triphenylphosphine)rhenium(V) 1, benzyl- 
tri(ethy1)ammonium oxotetrachlororhenium(V) 2 and trichloro(acetonitrile)bis- 
(niphenylphosphine)rhenium@I) 3 were used as precursors. The R ~ V  and R~III  complexes 
1-3 shown in Fig. 1 should allow chlorine substitution at a definite oxydation state. Initial 
ligand exchange experiments have been canied out in order to obtain neutral ,lipophilic 
compounds. 
Reaction of "NS3" with 1 in toluene furnished a grey powder of low solubility in common 
solvents. Its infraired spectsum showed broad bands indicating a polymer. Similar results 
have been obtained by the reaction of "NS3" with 2 in MeOH/MeCN/triethylamine. 
3 reacted with "NS3" in the presence of triphenylphosphine in MeC12 a formed violet 
campund 4 [Xmm = 500.2nm (MeC12)I. it was purified by column chromatography 
(silica, CHCl3). The elementd andysis revealed 1: 1 units of triphenylphosphinef "NS3" 
and additional chlorine. The structure of compound 4 cannot yet be interpreted with 
certainty on the basis of elemental analysis and 1~ NMR. 
The reduction route siarting directly from NW4ReO4 with an excess of ligand in EtOH was 
more sucessful. Two different p r h t s  5 and 6 are formed as illustrated by Fig. 1. 
Compoh~nd 5 a p p s  as a violet species in solution (EtOH), but it decomposes slowly. 
chlorhe was attaGhed to the rhenium ion, thus making 5 instable due to the 
resence of "native" ehloririe. In order to avoid this effect, firther experiments were 
. H ~ ~ e v e r ,  similar products were obtained which are good soluble in 
ar solvents to give a violet colour occured. 
6 was formed under similar conditions but in the presence of an 
exct-s of tn.pbenylphosphhee Polar cts wete removed by column chtomatography 
(silica, toluene) . After recrystallization from toluene, dark green needles (m.p. 234"C, 
decomp.) of 6 were obtained. 
Fig. 1: Some products obtained from R~W,  ReV and Rem. 
The UVIvis spectrum of 6 showed absorptions at 247, 306 and 461nm in MeClz. In the 
infrared spectrum no band of vRe=O was observed. The IH NMR s p m m  supported 
formula 6 Fig. 2). Here the shape of the methylene multiplet suggested 6 equivalent CHZ 
groups. Elementai analysis supplied a further evidence for the stnicture m ~ m e d .  
Up to ~ O W  tris(3-mercaptopropy1)amine has generally yielded ambiguous products .I*; 
deviant behaviour may be due to the steric condiüons. 
Elementai analysis of 6 : 
c24H27ms3Re C H Pi3 
M. 642,235 d c ,  (%) 44,84 9 17 
found (%) 44,% 
P- -- 
Fig. 2: 1I-I NMR sptnrm of 6 (CDS12) 
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18. A ROUTE T0 ALKYLAMMONIUM SUBSTITUTED R e 0  AND T c 0  
COMPLEXES 
H.Spies, M. Glaser, G. Görner, Th.Fietz 
Cationic technetium complexes attract considerable attention as potential tracers for 
radiopharmacological studies, e.g. as myocardium affine agents [I]. In view of this 
background, experiments have been undertaken to introduce a positive charge into the side 
chain of neutral rhenium and technetium complexes. 
A tertiary amino group in the side chain of neutral Tc 121 md Re complexes obtained 
according to our so-called 3+1 procedure [3], may be alkylated to produce the 
corresponding alkylammonium substituted complexes. 
The reaction route for (2-(diethylmethylmmoni~m)ethanthiolato)(3-thiapentane-1,5- 
dithiolato)oxorhenium(V) iodide 2 as a typical representative is ldescribed in Fig. 1. 
"L) 
ReOClJ + HSCH2CH$C%C%SH + HSCH2C%NEL) -----+ 
1 2 
2 + MeI 
- 
Fig. 1: Synthesis iof 3 
A 1 : 1 : 1.5 mixture of benzyltriethy1ammonium tetrachlorooxorhenate(V) 2, 3-thiapntane- 
13-dithiol, and 2-(diethy1amuio)ethanthiol in acetonitnlefmethmol is allowed tri ract  for 
lh  at O°C to form (2-(-diethylmino)ethanthiolato)(3-tfuag1,5-dithiol~t0)0~o 
rhenium(V). 
The product was separated from the reaction mixture by diluted hydrochloric acid in the 
form of a hydrochloride. The amine 2 liberated by sodium hydroxide solution and extracted 
by MeC12 was subsequently quaternated by addition of an excess of methyl iodide. Product 
3 was precipitated by cooling and recrystallized from EtOH. The yield of the red crystals, 
m.p. 170-181°C, amounted to about 38%. The salt is soluble in polar solvents such as 
water or ethanol. 
Eig. 2: Electropherogram of 3 
The cationic nature of the new compound was confirmed by capillary electrophoresis (Fig. 
2). The electropherogram (15kV, 40cm, 214nm, 0.01m sodium phosphate buffer, pH 7) 
shows a sharp peak at retention time 2.61min assigned to the cationic species, the peak of 
acetone used as neutral a reference substance at 3.67rnin and a low signal at 5.02niin caused 
by iodide. 
The infrared spectrum of 3 clearly shows the vRe=O band at 968cm-I (Fig. 3). The 
WIVis spectrum has bands at 226, 260(sh) and 364nm, similar to those found in 
corresponding neutral oxorhenium complexes with SSSIS coordination 141. The values 
confirm that the coordination sphere is not attacked by aikylation. 
'i"he IH NMR spectrum has a relatively complex shape due to the presence of different 
methylene groups in the molecule. The spectrum is consistent with the formula, even if not 
all  the intensities can be assigned to corresponding protons. 
Thus, alkylation of the amino group is a suitable route for preparation of " T c ~ R e - ~ ~ ~ ~ ~ ~  
ammonium salts. Furthermore, the exclusive aikylation of the amine moiety umk~lines the 
figh stability of Re-S bonds in this special type of sulphur coordinated com~lexes. 
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19. NEUTRAL .OXORHENIUM(V) COMPLEXES WITH MONOTHIOLI 
TRIDENTATE DITHIOL COORDINATION 
H. Spies; Th. Fietz; H.-J. Pietzsch 
In view of the fact that the rhenium nuclides lg6Re and IssRe emit beta particles with 
therapeutically useful energies, rhenium is induded in our efforts to design and evaluate 
new radiotracers for radiodiagnostic and radiotherapeutic purposes. 
With the aim of obtaining a series of homologous substituted Re compounds for 
systematical studies, e.g. for investigating the dependence of lipophilicy of the complexes 
on the length of alkyl chains linked to the complex core, we examined the usefulness of the 
"3+ 1" principle for preparation of new lipophilic Re complexes. This synthesis route, 
which involves simultaneous action of a tridentate dithiol ligand and a monodentate thiol on 
an appropriate meta1 centre, has already shown its suitability for preparation of neutral 
mixed-ligand complexes of Tc(V) [I J. 
Alkyl- and aryl-substituted oxorhenium(V) complexes ReO(SXS)(SR) with HSXSH=HS- 
CH2CH2-S-CH2CH2-SH or HS-CH2CH2-0-CH,CH2-SH and R = alkyl, (substituted) aryl, 
have been prepared by reaction of NBzEtJReOCI,] (I) with HSXSH and RSH according to 
Fig. 1. 
Fig. 1: Reaction scheme. 
The ~1-substituted complexes &-@ md &-d can be obtained directly from the reaction 
mixture when stoichiometncat amounts of (substituted) thiophenols and of HS-CH2CH,-X- 
=S;O) are mixed and added to stirred solutions of the corresponding 
amorrnt of 1 in a small volume of metlhanol at 0°C. The complexes, which precipitate very 
sson, are isolatd and purified by beulg dissolved in hot cfi10roform, drup-by-drop addition 
f ethanol md subs~uefit reduction of the solvent ta a smail volume. 
The aliphatic substituted compounds &-L and &-L do not directly precipitate under these 
conditions. The complexes are purified by column chromatography (silica gel, 2Ox2cm, 
methanol) which removes colorless by-products. On evaporating most of the solvent, 
crystals of &-k and &-k are formed. However, when using long-chained mercaptanes, 
crystallisation may prove impossible due to formation of oils. 
Analytically pure, crystalline compounds & -  arid &-k are listed in Tab. 1. The yields of 
pure compounds differ widely from 20 to 55 %. 
Tab. 1: 
Compound IR 1 FP. I  Re=O in IR 
k 
,2d 
2e 
4-CH,-C,H, 
4-C1-C,Hd 
CH, 
>310°C 
>310°C 
157-158°C 
960 
960 
966 
oxorhenium(V) (-1, which was chosen as a typical example of the class of complexes 
covered herein, shows a strong Re=O stretching band at 976cm-I (see Fig. 2). In IR 
recordings of all Re(V) complexes examined, we found the Re=O bands to differ from 952 
to 976cm-I whereas the wavenumbers of the respective bands of complexes S were generally 
lower than in complexes 3. In comparision to that values, the Re=O stretching band in 
ReOC1,- is found at about 1000cm-1. Analogous examinations of Tc=O complexes show the 
respective band at 920-980cm-1 [I]. 
Fig. 2: IR spectrum of 31  in KBr 
In the % stucly (Fig.3; solvent peaks omitted), the spectrum of &I in CDC1, exhibits 
an assernbly of Uhree broad signals for the protons of -S-CH,CH,-0-CH2CH,-S- at 4.68, 
3.72 and 3.25-350 ppm, which is not, however, symmetrical as expected. The 
mctrnodentate ligands profon signals are seen at 7.50 ppm, 6.95 ppm (2 aromatic 
protons eich) and 5.85 pprn (CH30). The Patterns of the methylene protons in the NMR 
spectra of the se* 2 (X=S) can be clearly distinguished from those of & (X= 0). Within 
the sulphut serks, tfre pattems d r~  not differ so much. In this respect the rhenium 
comportnds behave m c h  like to the anaiogous technetium cornpounds [I]. 
The UVIvis spectrum of & shows a broad maximum at hm=357nm (lge=3.83).In the 
UVIvis spectrum of the respective sulphur compound 2b two sharper maxima at 344nm 
(Ig&=3.92) and 410nm(lgs=3.94) can be detected. 
X-ray crystal analysis of both 3b and an alkyl-substituted example of the compound class is 
in Progress. 
Fig. 3: 1H NMR spectrum of 3b in CDC13 
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20. CHARACTERIZATION OF TECHNETIUM-99 COMPLEXES WITH 
MERCAPTOACETYL PEPTIDES (MAG3, M A e ,  MAG1 ) 
B. Johannsen, B. Noll, St. Noll, H. Spies, P. ~eibnitzl, G. ~ e c k l  
l~undesanstalt fur Materialforschung, D-1199 Berlin 
Havhg studied in detail the preparation of the oxotechnetium(V)complex of mercaptoacetyl- 
triglycin (MAG3) [I], which is an important renal fiinction agent, we wanted to learn and 
understand the effects of shortening the peptide chain ( going fkom MAG3 via MAG2 to 
MAGl) on the stmcture and properties of the Tc complexes. Shortening the peptide chain 
alters the donor atom Set fkom S N3 0 to S N2 0 and to S N 0, which may cause a different 
coirdination of technetium. 
Experiments 
Complexes were prepared by ligand exchange reactions starting fkom Tc(V) gluconate. 
Mefhoh 
The iduence of the molar ratio of the reactants on the occurrence of products was studied by 
UV/vis spectroscopy (Specord M40). The chromatographic behaviour was determined by thin- 
layer chromatography with 95% ethanol as the solvent and by HPLC on an RP 18 column 
(Nucleosil, 25cm) with 0.05M phosphate buffer pH 7.4 as the eluent. The charge of the 
complexes obtained was determined by thin-layer electrophoresis with phosphate buffer 
soiution pH 7.0 and ilycine buffer pH 2 and pH 10. 
Variation of fhe -glucoprate molar rafio 
100p1 O.OIM potassium pertechnetate, 0.5ml 99m~c-generator eluate and lOOpl 0.01M 
stmous chlonde in 0.01M Hel are added to 1.51111 0.05M sodium gluconate. 
l*l0-5mole MAG3 MAG2 or M& as the ligand is dissolved in 100p1 water and the molar 
equivdents according to the molar ratio are added to the Tc-gluconate solution, for the 
ar ratio 100/1 l il~"?niol igand is dissolved in 1 d  O.1M NaOH. 
Preparafion af Ph&s[TcOWG2)] 
, dissolved in lml 0.2N NaOH, is added to 3ml TG gliiconate solution 
itkm of 8.4~10'*~mol tetraphenylarsonbm chloride, dissolved in 200pl 
cipitates, Pvhich is colle~ted md washed with etherlethanol. 
= 64%) of a brown crystaüine 
Anal. Calc. for C32H32N206SAsTc: C: 51.43; H: 4.32; N: 3.75% 
Found: C: 51.57; H: 4.91; N. 3.21% 
IR: 960cm-l vTc=O 
UVIvis (ethanol) (hmax (log E)): 345nm (3.16) 
IH NMR: 7.80ppm (m, 20H) phenyl; 4.6614.25ppm (AB, 2H) and 4.07pprn (s, 2H) 2 x N- 
CH2, 3,85/3.66ppm (AB, 2H) S-CH2. 
Results and Discussion 
Studies of complex formation 
Various Tc-species are obtained, depending on the 1igandfTc molar ratio (Tab.1). Complex 1 
(rp0.6-0.7) is obviously the 1:l complex because of its identity with the rf of the 9 9 m ~ c  
radiopharmaceutical preparation for MAG3 and with the rf of the isolated Tc-MAG2, 
Complexes 2 and 3 (rf = 0.3-0.4 and rf = 0-0.1) occumng during the radiopharmaceutical 
preparation of Tc-MAG3 too [1] can be considered to be Tc complexes with a w e r  
ligandlTc ratio. With increasing pH value >11 they can be transformed into the klnetically 
stable complexes 1 @AG3 and MAG2) as well as into complex 2 (MAG1). 
Tab. 1: Ligand exchange of Tc gluconate with MAG3, MAG2 and MAG1 at various 
ligandmc ratios. The species were separated by TLC on silica gel with 
95%ethanol as the eluent. 
Tab. 2: Electrophoretic behaviour - anionic migration of the kinetically stable 
complexes related to TcO4- as an internal standard. 
Sr 
ft is of inrterea to obtain Uifomation about the relative reactivity of the donor atoms, which 
ckanges when tfie ligand is changed, e. g. by shortening the length r>f the peptide chain, 
Vandebrouck et al. [2] have dready shown an increase in the complexation strength fiom 
MAG3 to MA% as weil as the prominente of MAG2, having the highest ability to form a 
complex with 99m~c. 
It is obvious that no 1: 1 complex can be formed with MAG1 as a ligand. In neutral solution a 
TcOL2 complex is formed, which is extractable into methylene dichloride &er adding a 
lipophilic cation (NBU~+). The anionic mobility is the Same at pH 7 and 2. Therefore, the 
carboxylic groups of both ligand molecules are involved in bindig technetium. In alkaline 
solution MAG1 possibly acts as both a tridentate S, Ny 0 ligand and a monodentate S ligand, 
since the electrophoretic migrz~tion of the Tc complex depends on pH (Tab. 2), one fiee 
carboxylic group in the complex molecule is assumed. 
T C - M G ~  
Reaction of MAG2 with technetium(V) gluconate in neutral aqueous solution results in a 
spectrum of different compounds. The ratio af compounds changes with the ligand to metal 
molar ratio, which is qualitatively Seen in a change of colour after addition of various amounts 
of the ligand to the precursor. The maxima in the UV spectrum of the reaction mixture are 
found as 345nm for 1:1, 370nm for 8:l and about 400nm for a 100:l 1igand:technetium molar 
ratio. In TLC, up to three species were detected at ratios greater than 1:l. 
The 1: 1 Tc-MAG2 complex diiers fiom that of MAG3 by being formed at even a slight excess 
of ligand, which indicates that O-donors may play a remarkable role in stab'img the TcOJ)O 
core. When the reaction of MAG2 with technetium(V) gluconate is c d e d  out in an alkaiine 
medium, a pure component occurs regardless of the molar ratio. It was isolated as a 
tetraphenylarsonium salt. 
Further Support for the structure of AsPhq[TcO(MAG2)].C2H~OH was given by X-ray 
crystailography. A perspective view of the complex anion is shown in Fig. 1 asld emphasizes 
that the compound belongs to the weil-known group of square-pyramidal oxotechnetium~ 
complexes. (Selected bond distances and angles are sumtnarized in Tab. 3). 
Tc-MYGjl 
With as the ligand, the weli-known anionic 1:l complex possessing a free ~arko~yf 
group is formed in alk.aline solution, or the ligancVTc rgtio in figand exchange reacdons 3s kept 
low. Any excess of ggand over Tc favours the 2: f complex and, at at 'higher ~ X F ~ S S ,  
the 41 species. in the latter cawe oniy reacts as a monodeatate thio1. Irltemned'rates 
occur due to the high reactivity of t3he eee rnercapto group in the JSgand, fa~ouling c~mptexes 
with Iigand/Tc ratios higher thar3.1,"Thfs 3s trw of any excess of& wter TG 3n tfie 
solution, 30th a I:?. and Ir4 spe~ies wert: identified and sepamted ftom the 1.1 
complex by EPLC 
I Fig. 1 : Molecular anion of A~P~~[TCO(S-CH~CONH-CH~-CONH-CH~-COO)] 
I I I 3,5 6 3  10.3 Rt [mi 
Fig. 2: Fig- 3 : 
Separation by HPLC of three Tc-MAG3- UV/vis spectra of Tc-MAG3-species 
complexes on an W-18 column with 15% 1 predominant 1 : 1 complex I 
methanoI in 0.05M potassiumdiiydrogen- 2 predominant 1 :2 complex 
phosphate, pH 5-85 3 predominant 1:4 complex 
Tab. 3: Selected bond angles and distances for [TcO(MAG2)] 
Bond lengths (4 
TC-01 1.644 TC-NI 1.968 Cl-S 1.828 
TC-02 2.016 TC-N2 1.968 Cg-02 1.314 
TC-S 2.271 Ch-05 1.230 
Bond Angles (deg-) 
0 1 -TC-S 110.4 S-TC-N2 133.7 
0 1 -TC-NI 109.4 S-TC-02 88.3 
0 1 -Tc-N2 115.8 NI -TC-N2 78.9 
Conclusions 
MAG, ligands (n = 1,2, 3) easily form various TcVoxo complexes. Depending on the reaction 
conditions, such as Tclligand ratio and pH, they may act as monodentate, bidentate or 
tetradentate (except n = 1) ligands. The good donor quality of the mercapto group, whkh 
outbalances the amide-N and carboql-0 atoms, triggers the initial formation of TcOlL4 under 
excess ligand conditions. The chelate effeet ultimately leads to 1 : 1 complexes. This process can 
be facilitated by activiation of the amide-N at pH >11 as well as by low 1igandITc ratios. 
MAG2 differs from MAG3 in that it provides interesting S, N2,O coordination. 
[TcO(MAG2)] is a Tc compound with sulphur-containing ligands within the weli-known group 
of square-pyramidal oxotechnetium(V) complexes in which a carboxylic group is involved in 
the equatorial plane. The distance of the Tc-O(carboxy1ate) bond is relatively short (2.0IOA) 
compared, for example, to that of the trms-coordinated carboxylic group in TcO(penl)s (pen F 
peniciilamine) (2.214A) 131, which is in accordance with the high stability of T G - W  
observed in the above experiments. 
Shoriening the peptide chain length and bl~ocking the carboxyic group in the Egand molecule is 
expected to male 2:1 compiexe~ the main products. This has been coniiimed for 
alkaline solution MAGl possibly acts as both a tridentate S, N, 0 ligand arid. a 
ligand. 
Referenees 
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21. COMPLEX .FORMATION OF TECHNETIUM WITH THE METHYL 
ESTERS OF MAG2 AND MAG1 
B. Noll, St. Noil, B. Große, B. Johannsen, H. Spies 
Mercaptoacetylglycine methyl ester (MAG2 ester) and mercaptoacetyldiglycine methyl ester 
(MAG1 ester) were included in our investigation on complex formation of SHIamide 
ligands with technetium and rhenium. Our studies are aimed at finding out how blocking the 
carboxylic groups influences the complexation reaction, with a view to finding an approach 
to new lipophilic species. 
Experimental 
The influence of the molar ratio of the reactants on the occurrence of Tc- complexes was 
studied by UVlvis spectroscopy (Specord M40). The chromatographic behaviour was 
determined by thin-layer chromatography with 95% ethanol as a solvent and by HPLC on 
an RP 18 column (Nucleosil, 25cm) with 0.05M phosphate buffer pH 7.4 as an eluent. The 
chatge of the complexes obtained was determined by thin-layer electrophoresis with 
phosphate buffer solution pH 7.0 and glycine buffer pH 2 / pH 10. 
TLC: of the ligands and their precursors was perfomed on silica gel sheets (~ilufol) with n- 
butanoUacetic acidlwater 4: 1 : 1, spots were detected by iodine or ninhydrin under a UV 
lamp. 
Synthesis of mercaptoacetyl diglycine ester (MAGZ, ester) 
~lozoacetyl-digbcirte (modified procedure of [I]): 
To a solution of log (0.Wmol) of glycine anhydride dissolved in 5 0 d  of 2N sodium 
hydroxide, 7.8~11 of chloioacetyl chloride and 24ml of 5N sodium hydroxide were added 
over 45min while sMng  in an ice bath. After acidification with 40ml of 5N hydrochloric 
acicl cbnoroacetyl-diglycine crystallized while cooling. The product was separated, washed 
with ice-water m d  recrystallized from water. 
Yield: 7Sg (41 5%) 
Mp 174OC, q 0.70 (iodine) 
IR 3350; VC-JOH 1730; vc=o 1675,1630; 6~ 1550 cm-1 
Be~oyZmrcaptoacetyl diglycim: 
.O$mol) thiobenzoic aGid was diss in 20ml methanol and neutralized with 
Z'his solu~on was dropped ta 5.2% (0.025mol) of chloracetyl-diglycine in 
1 litre of dry methanol while stirring unaler nitrogen. After 12h the reaction was completed 
and the solvent was removed by rotary evaporation. To the residue 2N hydrochlork acid 
was added, the solid was separated and washed with warm water, followed by chloroform, 
acetonitde and diethylether. 
Yield: 6.9g (89%) 
I Mp 194"C, rf 0.80 (iodine) 
IRmr) :  v m  3450; VCOOH 1730; VC=O 1660,1640,1580; 6m 1540cm-I 
Benzoylmercapto?zcetyl diglycine methyl ester: 
I 
To lg (3.2mmol) benzoylmercaptoacetyl diglycine dissolved in 2001111 methanol, 5g 
methanolic cation exchange resin DOWEX 50WX8 and 5g ZEOSORB 4A were added and 
the mixture was refluxed for 19h while stirring vigorously. After cooling the resin was 
filtered off and the methanol was distilled on a Rotavapor. The viscous yellow oily residue 
crystallized at 4OC. 
I 
Yield: 857mg (83 %), rf 0.8 (uv) 
IR @Br) VC=O 1640; VCOOR 1680; 6 m  1550cm-l 
I Mercaptoacetyl diglycine methyl estec 
0.857g (2.65mmol) of benzoylmercaptoacetyl diglycine methyl ester was dissolved in 68ml 
methanol. Under an N2 atmosphere, 286mg (5.3mmol) sodium methylate was dropped to 
the solution while stirring. Stirring was continued for 60min, and after neutralization with 
methanolic DOWEX 5OWX8, the mixtnire was fdtered and methanol was distilled On a 
Rotavapor. 25ml water was added to the residue and the solution was extracted t w i ~  with 
15ml b&ne. The volume of the aqueous solution was reduced to lOml and introd~ced 
onto a column filled with D O W X  50WX8. The eluted product was obtahed by f r e ~ e -  
drying . 
Yield: 176mg (30%) 
20mg of this product was purified by liquid chromatography on Sephadex G10 wifh Vvater 
as an eluent and a pump speed of 20miUh, Detection was caMied out by a flo%v-through 
analyzer measuring the refractometric index. 
Yield: 16.4mg (82%), Mp. 129'C, rf 0.5 (nulhydrin) 
IR @Br) V C = ~  1650; VCOOR 1750; 6 m  1575 cm-1 
IH NMR (DMSO) TMS 6 3.2 (-CH2-S11,2H); 6 3.6 (-OCH3-,3@; 6 3.7 {-sB,l@t~); 
S 3.8-3.9 (-iCI32,4H); 6 8.3 (-C0-NH92H) 
I 
Mercaptoacetyl glycine &er (MAG1 &er) 
Chloroacetyl glycine(modi$ed procedure of P]): 
7ml (1.2 equiv.) chloroacetyl chloride and llOml 1N sodium hydroxide were added to a 
solution of 5g (0.07mol) of glycine in 67ml of 1N sodiium hydroxide over 30min, while 
stirring in an ice bath. Then the mixture was acidified with 20ml 5N hydrochloric acid and 
the product was dried by rotary evaporation. The residue was three times extracted with 
acetone and the acetonic solution was reduced to a volume of 15ml. After addition of 30ml 
chloroform, a viscous oil was obtained which was separated and extracted with 300ml of 
hot diethyl ether. The ether solution was reduced to a volume of 50ml and the product 
crystallized while cooling to yield chloroacetyl glycine. 
Yield: 3.9g (39%), Mp 81 "C, rf 0.75 (iodine) 
IR@&): v m  3320; VCOOH 1730; VC=O 1620; 6 NH 1540 cm-1 
Benzoylmercaptoacetyl glycine: 
5,7g (0.04mol) thiobenzoic acid was dissolved in 20ml methanol and neutralized with 
sodium methylate. This solution was dropped to 3.2g (0.021mol) of chloroacetyl glycine in 
750ml dry methanol while stirring under nitrogen. Stirring was subsequentiy continued for 
12h and then the methanol was removed by rotary evaporation. 2N hydrochloric acid was 
added to the residue, yielding a brown oil, which was separated and dissolved in 80ml 
chloroform. While ml ing  and stirring vigorously, tlhe product crystallized and after 
separation it was washed with water, chloroform and diethylether. 
Yield: i.5g (27%), Mp 136"C, rf 0.85 (iodine) 
IR@&): V* 3380; VCOOH 1740; VC=O 1675,1620; v m  1540 cm-1 
Benzoylmercaptoucetyl glycine methyl estec 
To 3.2g (0.0126mol) benzoylmercaptoacetyl glycine dissolved in 275m1 methanol, 6ml of 
methanolic cationic exchange resin DOWEX 50WX8 and 3g Zeosorb 4A were added and 
e mixture was refluxed for 30h and then filtered. The methanol was distilled on a 
Rotavapm anid the viscous red oily residue was allowed to crystallize at 4°C. 
Yie1d: 1.8g, rf 0.75 (Uv) 
Mercaporzce@l methyl e s m  
3 % ~  benzoy1mer~ptoacetyi glycine ester was dissolvd in 25ml methanol in a round 
botefe. After addition of 2mg of PdlCaC03 the bottle was eonnected to a vacuum apparatus, 
md then hydrogen was added to a pressure of 66kPa. The reaction mixture was 
VitgorWsIy for 30min while adding 0.7ml sodium methylate in 5mi methanol. The 
neuwlzed with cationk exchmge resin DOWEX 50 *WX8 and the reaction 
product separated by freezing dry. The residue was extracted twice with 3ml benzene and 
purified by liquid chromatography on a Sephadex G10 with a flow-through analyzer 
measuring the refractometric index. The eluent was water, the pump speed was 20mllh and 
the final product was isolated by freeze-drying. 
rf 0.7 (ninhydrin) 
Anal.: MG 163 C5Hg03NS 
calc.: C 36.80, H 5.55, N 8.58, S 19.65% 
found: C 36.15, H 5.70, N 8.25, S 19.51% 
IH NMR(DMS0) TMS 6 3.5(-CHz-SH,2H); 6 3.6(0-CH3,3H); 6 3.2(-SH, 1H); 
Preparation of the Tc comple~ces: 
Complexes were prepared by ligand exchange reaction starting from a Tc-gluconate 
complex. The 99~c-~luconate complex is prepared by addition of 1 *10-6mol stannous 
chloride to 1 u 10-6mol potassium pertechnetate in 2ml 0.05M sodium gluconate solution. 
1*10-Sm01 ligand is dissolved in l*l water and the molar equivalents according to the 
1igandITc molar ratio are added to the Tc-gluconate solution. 
Results and diicussion 
Tc-MAG2-methyl ester 
As indicated by the UVIvis spectra, variation of the ligandlkchnetium ratio results in 
various complexes of Tc-MAG2-methyl esters. At a 1:l ligandltechnetium ratio the 
maximum occurs at 360nm, an increase to 2:l doubles the extinction at ihe same 
wavelength. At a higher molar ratio a second maximum occurred at 400nm, which vani~hed 
at pH > 10. 
Complex solutions wntain two species sepmble by thin-layer ele~troophoresis. The p & 0 n ~  
of both components in the 1:2 and 1:4 reaction mixtures are fisted in Table I, When the 
complex solutions are adjusted alkaline, only component 2 is detecbble. A pH 2 it has thr: 
sarne relative electrophoretic mobility urel. = 0.30-9.35 as at pH 10. 
HPLC on an RP 18 column with 82% phosphate buffer pEI 7.4 md 18% acetoriitde as ari 
eluent permits separation of the neutral reaction muLhire into four mmprrnents, whereas the 
alkaline solution shows only one wmponent (Fig, 1). 
Tab. 1: Proportions of anionic products in the Tc-MAG2-methyl ester System depending 
on the Tc / ligand molar ratio as determined by thin-layer electrophoresis (urel = 
relative electrophoretic mobility of Tc-components with respect to pertechnetate) 
n of the Tc-MAG2-rnethyl ester reaction mixture by HPLC on RP 18 
2) With 82% phosphate buffer pH 7.4 and 18% acetonluile as an eluent 
A - neutral suIufriOr, B - a W h e  so1ution 
Tc-MAG1-methyl ester 
In the UVIvis spectnim there is an absorption at 370nm, the maximum of extinction is 
achieved at the molar ratio of 1:4. With a much higher ratio (150) a second maximum is 
observed at 400nm. The reaction mixture of the molar ratio 1:4 was separated into two 
anionic complexes by electrophoresis at pH 7 with the relative electrophoretic mobilities of 
0.20 and 0.45 Pig. 2). 
The proportions of the two species depending on the molar ratio of the reaction mixture are 
shown in Table 2. 
Tab. 2: Distribution of Tc-complex species in TcIMAG1-ester reaction mixture 
deterrnined by thin-layer electrophoresis, phosphate buffer pH 7, fied 
strength 20Vlcm. 
M Y  
1 : l  
1 : 2  
1 : 4  
1 : 8  
Distribution of activity[ %] 
complex 2 
ure1 - (0.45) 
- 
20 
Tc-gluc. 
(urd -0.35) 
-100 
50 
- 
complex 1 
(urel -0.2) 
- 
30 
61 
- I 39 47 43 - 
Fig.2: Electropherogram of the Tc-MAG1-methyl ester reaction mkture in phosphate 
buffer pH 7, field strength 20V/cm, electrophoresis time 45rnin. 
In neutrai solution more than one Tc-species were detected by several analytical methods in 
the Tc-MAG2 and Tc-MAG1-methyl ester reaction mixtures. These are formed directly by 
ligand exchange, s t . g  from the Tc gluconate. According to the results obtained by 
HPLC, four different species are formed in the Tc-MAG2-methyl ester system, in alkaline 
solutim only one species was found, which differs in its analytical behaviour from those 
obtaind in neutral solution. 
Refeaences: 
Cl] Fis~her, E., Ber. 39 (1906), 2931 
[2] SRvene, ]P+ A. et aZ„ J, Biolog, ehern, 61 (1924) 
22. HPLC AND CAPILLARY ELECTROPHORESIS OF S-PROTECTED 
MAGn-ALKYL ESTERS 
B. Noll, K. Landrock, St. Noll, G .  Gömer 
For synthesis of allcyl ester of S-benzoyl-MAGn (n = 1,2, 3) by reactioii of the 
corresponding carboxylic acid, a method is required for analytical determination of both 
compounds. 
The content of the S-benzoyl-MAGn ester in the reaction mixture was determined by HPLC 
and by capillary electrophoresis. The methyl esters of the S-benzoyl-MAGn glycines were 
prepared as described by [I]. The purified S-benzoyl-MAGn derivatives and the 
corresponding acids were used as reference substances. 
HPLC separation of S-benzoyl-MAGn from the S-benzoyl-MAGn ester was performed on 
an RP 18 column (Hypersil ODS, 2SOx4.6mm) with phosphate buffer pH 7.0lmethanol 
70130 (v.v) as an eluent, a better resolution of the S-benzoyl-MAGn-derivatives is obtalned 
by using 0.1 % phosphoric acid J methanol70/30. 
The dependence of the retention time on the separation conditions is shown in Fig. 1. 
The capillary electrophoresis experiments were carried out with a P/ACE instrument from 
Beckman using untreated füsed silica capillaries of 40 cm length, 0.01M phosphate buffer 
pH 7 as an electrolyte and working with a voltage of 15 kV. 
The results obtained by HPLC are in good agreement with those obtained by capillary 
electrophoresis (Fig. 2). 
=. 9 E:. 
- 
C. 
- 
-. 
Fig.2: Separation of S-benzoyl-MAG, derivatives and the corresponding methyl esters by 
capiilq electrophuresis, A: S-benzoyl-MAG3 /S-benzoyl-MAG3 methyl ester, 
B: S-benzoyl-MAG2 IS-benzoyl-MAC32 methyl ester, 
C: S-benzoyl-=G1 /S-benzoyl-MAG1 methyl ester 
23. TRITIATION OF BENZOYL-MAG3-ERGOLINE AM) ERGOLINE 
St.Nol1, B.Große, ~ . ~ i n d e i s e n l ,  ~ . ~ . ~ c h u l z e 2  
~nstitut für Oberfiächenmodifizierung , Leipzig 
clo Schering Aktiengesellschaft, Berlin 
Benzoyl-MAGyergoline and ergoline were tritiated by catalytilc hydrogen isotope exchange 
and investigated by radio thin-layer chromatography and 3~ NMR spectroscopy. 
The tritiation of benzoyl-MAGyergoline (Fig. 1) results in 20% of tritiated MAG3-ergoli- 
ne, 50% "acetyltriglycine-ergoline" and 30% undefinable by-products. The experiments re- 
v a l  that under conditions of a catalytic hydrogen exchange, not only is the protection 
substituent of the molecule split off but the sulphur-carbon bond is also partially split. This 
can be demonstrated by radio thin-layer chromatography, UV and NMR spectroscopy arid 
by comparison with reference substances. 
Fig . 1 : S tntcture of the benzoyl-MAG yergoline molecule 
It was important to know whether ergoline in MAG3-ergoline remained unchmged WV&X 
the conditions of labelling and which positions of the molecule were labelled with tritiurn. 
Eor this reason ergoline was labelled by catalytic isotope ex~hange under the Same cimdi- 
tions as MAGg-ergoline. The tritium labelled ergoline obtained with a radio-~hemicd P U ~ ~ Y  
of 95 % was investigated by 3~ NMR spectroscopy. 
The measurements were Camed out with a BRUKER AM-250 System at a ff.~ilenCY of 
250MHz and a 3~ frequency of 266MHz using a 5mm 3~ selwtive probe head with 'H 
decoupling coils. The solvent was Dhf$O-D6 (calibmtion at 2,s 1ppm in botb 
2 shows the 3~ NMR spectnim (I) and the IH NMR spectnim 1) of ihe labe3 
The fact that ergoline remains unchanged during tfie labellling process ir; de 
]H NMR spectrum, which is identical with that of an unlabelled 
also indicates the labelling pasitions in the ergoline m d m l e  ;?[s 
Fig. 2: 3~ and 1~ NMR spectrum of ergoline and structure of ergoline molecule 
Experiments: 
I. Tritiation of benzoyl-MAGs-ergoline: 
3.0mg benzoyl-mAG3-ergoline was dissolved in 0.25ml water and 0.25ml ethanol in a 5ml 
round bottle. After addition of 148mg Pd-black, the bottle was connected to a vacuum ap- 
paratus, evacuated and then iritium gas (50% tritium, 50% hydrogen) was added up to a 
pressure of 55Wa. The reaction mlxture was stirred vigorously for 3h. The catalyst was se- 
parated by centnfigation and washed with water several times. The solvent was freeze dried 
and labile txitium was separated by dissolving the residue in aqueous ethanol and lyophili- 
zing it three times. 
The product obfained has a radioactivity of 1-60GBq and a radiochemical purity of 20 % as 
kund in ct Sllufo~fh-butmol/a&c acidfwater chromatographic System, 
2.TBtiation of ergoline: 
The tritiagon of ergoIrne took place under the same conditions as that of benzoyl-MAG3- 
ergcpiline. 
The produet obtahed has a mdioacövity of I.91GBq and a radiochemical p u ~ t y  of 95 5%. 
- 
24. RHENIUM(V) GLUCONATE AS PRECURSOR FOR PREPARAFON 
OF RHENIUM COMPLEXES 
B. Noll, U. Kolbe, St. Noll, H. Spies 
Preparation of oxotechnetium(V) complexes is conveniently based on ligand exehange 
reaction on reactive Tc(V) precursors. Among them, Tc gluconate is particularly well 
qualified for both the synthesis of solid Tc complexes and for "carrier-{added" preparations 
used for biological studies, because aU reactions are carried out in a neutral aqueous 
medium, the exchange reaction proceeds rapidly with a variety of ligands, and the resulting 
Tc complexes are, as a rule, of a high radiochemical purity [1,2], 
We were therefore interested in making available the corresponding rhenium gluconate for 
synthesis of rheniumw) complexes. Preparation of Rew) gluconate is somewhat more 
complicated then preparation of Tc gluconate because perrhenate is less reducible than the 
pertechnetate ion. The preparation of Rew) gluconate solution is described and subsequent 
exchange reactions with are carried out benzenethiol and mercaptoacetyldiglycine (MAG2) 
as typical representatives of sulphur donor ligands are c d  out. 
Experimental 
Wlvis spectra were recorded on the spectrophotometer Sword M40, iR spectra 0x1 the 
Specord M80. The chromatographical behaviour was detemined by HPLC on sul 1RP 18 
colurnn with 85 %(VIV) phosphate buffer pH 7.4 / 15% methw.4 as an eluent. "rtie capi1lary 
electrophoresis experiments were carried out with a P/ACE instrument from $ec:kman uaing 
untreated fused silica capillaries of 20 and 40 cm length, OJIlM phosphate büfft3r pM 7 ilS 
an electrolyte, and working with a voltage of 15 kV* 
Spectrophotometric control of the reduction ofperrhenate by stafinom chlonde 
2.75ml 0.5M solution of sodium gluconate and 0.58ml 0.15M (8.7*1~-jmol) ammoniüm 
perrhenate are degassed with argon in a closed cuvette ( l~m).  Then 1XSjd 0,SM 
5mol) stannous chlonde in 0.1M H C ~  is introducd hto the 
time function of reduction is recorded, 
Rhenium gluconate 
25ml 0.1M sodium gluconate ( 2 . 5 * ~ - 2 d )  arid 
Ammonium tetrakis(benzenethiolato)oxorhenate(V) NH@eO(SPh)4] 
304 thiophenol (about 0.2mmol) was added to 2ml Re gluconate (0.05mmol). The 
resulting complex, which formed within one minute precipitated as black crystals, which 
were separated by fdtration and washed with water and ethanol. 
Yield: 16mg (SO %) 
Anal. Calc. for C24H24NQSqRe: C 43.88; H 3.68; N 2.13; S 19.52 % 
Found: C 43.76, H 3.40; N 1.96; S 18.87% 
IR spectrum: vRe0 = 950cm-1 
Tetraphenylarsonium (2-mercaptoacetyldiglycinato-S, N, N, 0)oxorhenate (V) 
AsPh4r;ReO(hUG2) J 
lOmg MAG2 (0.05mmol) dissolved in lml 0.1N NaOH was added to 2ml (0.05mmol) 
aqueous Re(V) gluconate solution while stimng. After standing for 15rninutes, 19mg 
(0.05mmol) tetraphenylarsonium chloride, dissolved in 0.5ml water, was added. The 
reaction mUrture was extracted with methylene chloride (3 X 2ml), the combined extracts 
were dried over sodium sulphate and evaporated to dryness. Recrystallization of the residue 
from acetone produced 31mg (0.04mmol) dark brown crystals. M.p.: 203-205°C 
Anal. Calc. for C30H26N205SAsRe: C, 45.74; H, 3.33; N, 3.56; S, 4.07% 
Found: C, 45.80; H, 3.31; N, 3.55; S, 3.86% 
1~ NM[R (DMSO-d6): 7.80ppm (m, 20H) phenyl, 4.83/4.l6ppm(AB, 2H) and 4.Olppm 
(s, 2H) 2x N-CH2, 3.89/3.62ppm (AB, 2H) S-CH2. 
(E;Bi): 976 cm-l VRe= Q 
VV/vis (ettianol) (Lmm (lg E)): 412nm (2.15) 
Results and discussion 
e the reduction of the pertechnetate ion by stannous ions in an excess of sodium 
s place fast and in quantitaty 611, reduction of perrhenate did not immediately 
rate depends on the concentration of perrhenate. At concentrations of 
< 6 x 1 0 - ~ ~  the reduction is incomplete if not impossible. At higher 
tion is complete, with clean conversion to the oxidation state +V. 
the Pennation of Re gluconate is shown by a decrease in the 
absotption of the perrhenate ion (UV spectnim of NHqReQ, Fig. 1) and the occurrence of 
a band at about 620nm irrdi~tulg Rew) gluconate. The increase of the absorption 
maxlmtsm at 625nrn as a function of time is depicted in Fig. 2. 
The blue coloured, clear solution of rhenium gluconate obtained in the concentration'range 
of 5-7*10-2~ is ready for use. As a frozen mixture under nitrogen, the solution can be 
stored for several weeks without any signs of decomposition. 
Fig. 1: W spectrüm of a 3 .8 i10-4~  aqueous solution of ammoniurn perrhenate 
The Re gluconate complex was separated from perrhenate by 3-IPLC on an W 18 cohmn 
with 85% phosphate buffer pH 7.4 / 15% methanol as an eluent (X&& 
gluc. = 2Smin). The anionic behaviour was determined by ~ap21läly 
As known from Tcw) gluconate, an excess of ligand is requIt& 
rhenium complex in aqueous solution. Attempts to isolatce fhe rismpounds 
preparation is nevertheless suitable for exchange racfions, TfIe fonowhg exp&iaienQ 
carried out with S and S/N donor Iigands indir~fly confkm the axida~on $Bk 4-Y' 
gluconate. 
1 .  
400 600 800 h [nm] 
Fig. 2: Reduction of ammonium perrhenate (C = 2.5*10-2~) in a 0.5M sodium gluconate 
solution by lmol stannous chloride/mol ammonium perrhenate, increase of the 
620nm band within 60min 
The reaction of Re gluconate with benzenethiol (molar ratio Relbenzenethiol 1:4) is 
completed within one mimte. The complex precipitated was isolated as the arnmonium salt 
and the anion was found to be identical (elemental analysis, UVIvis-spectrum, infrared band 
with the characteristic absorption at 949cm-I for Re=O ) with that prepared from 
[ReOCLjj- 131. 
In a similar manner ASP~~[R~O(MAG~)]  was obtained in good yields. The compound 
corresponds to the analogous Tc complex described in 143. 
The facility of preparation and ability of Re(V) gluconate to react with S(N) donor ligands 
under mild reaction conditions demonstrate the usefulness of Re(V) gluconate as a precursor 
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25. SYNTHESIS OF A DADT PRECURSOR 
T. Brankoff, H. Spies 
Baidoo et al. [1,2,3] recently reported a new route to bifunctional Tc diaminodithiol chelates 
involving reaction of a reactive thiolactone precursor (1) with an appropriate arnine. As this 
method seems to be a promising approach to Tc coupled biomolecules, which we are very 
keen to achieve, we worked on the synthesesis of the thiolactone precursor following Baidoo's 
procedure. 
Following the procedure [2], the eight-step synthetic sequence was accompiished with a 5% 
overall yield. The reaction scheme is Seen in Fig. 1, 
The yield of 2,2'-dithio-bis(2-methylpropanal) (2) fiom synthesis with isobutyraldehyde (lmol) 
according to [4] in two batches was 70%. (2) was converted into 3,3,10,10-tetramethyl-1,2- 
dithia-5,s-diazacyclo-4,s-diene (3) andogue [4,5]; the yield of cmde substance was 70%. The 
product of sodium borohydride reduction of the Schiff base in ethanol at 25OC is hexahyrlro- 
6,6,9,9-tetramethyl-1H-imidazo[2,1-d][l72,5]dithiazepine (4) [2,3,6] with a yield of 80%. N- 
alkylation of (4) with methyl iodide in the presence of 50% KF on celite [2,3j produced 
hexahydro-l,6,6,9,9-pentamethyl-1~-imidazo[2,1-d][1,2,5]djthiazePine (5) in a yield of 82% 
(5) was obtained as a colourless oil, which solidiied &er lyophilization in vacuum and coofing 
at 5OC. 
Cleavage of both rings of (5) into 2,2,4,9,9-pentamethy1-4,7-diaza-l,~O-decediol (6) was 
accompiished with Li- in dry tetrahydrofuran under argon [2,3], The fiee base was imme- 
diately converted into the dihydrochloride. Nevertheless no more than a 35% $dd was 
obtained. For protection of the SH groups in (6) p-methoxybenzyl chloride [2-,33 WS used. 
The product (7) results in a 70% yield in the form of the diirochloride, dIty1atirrn ofthe 
second nitrogen in (7) was carried out with ethyl bromoacetate [2,3] yielding (8) h about 56 
Compound (8) serves as the stock fiom which 4-[2-[(~-mer~;a~to-2-methy3prop~l) 
amino]ethyl]-6,6-dimethyl-2-thiomorpholinone (1) will be obtainrsd in anlhydfou~ EU? i 
apparatus [7], if necessary. 
The compounds synthesized (Tab. 1) were characterized by -R fSpeco 133 
spectrometry (Bruker, 250 MHz) and elementd anakysis, The calctttated vdues oftk demm- 
tal analysis were confirmed. For TLC, silica gel60 F454 (h.ierck)# CHC13iCH"sOE = 
iodine vapour were used . 
Tab. 1: Analyticd data of compounds 2 - 8 
Comp. m.p.Jb.p. 
/oc/ 
b.p. 80 - 90 
(1 0-l~orr) 
m.p. 164 - 166 
(ethyl acetate) 
m.p. -20 
133: b-p. 122 
12.4 . 1 0 - ~  Torr) 
m.p. 175 - 180 
oil 
TLC 
Eu 
0.70 
Fig. 1: Synthesis route 
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26. SEARCH FOR REDOX-ACTIVE MARKERS IN RADIOTRACER- 
DESIGN 
R. Bergmann, St. Noll, B. Grosse, H. Spies, B. Johannsen, W. Brandau 
1 8 ~  and 1231-labelled nitroimidazole derivatives have become known as hypoxic cell markers 
[I-41. It seems desirable to develop appropriate 9 9 m ~ c  labelled candidates, as well as 
exploring the potentials of other redox-active substrates of biochemical reactions, which may 
prove to be an enrichment of diagnostic nuclear medicine [9]. 
Bador et al. [5] have demonstrated that drugs can be selectively delivered to the brain using a 
dihydropyridinelpyridiniurn salt redox delivery system. This type of dihydropyridinelpyridinium 
salt redox delivery system may potentially be useful for trapping tracers in the brain. If any 
lipophilic Tc tracers equipped with the dihydropyridine moiety are available, they should be 
able to Cross the blood-brain barrier (BBB) due to their lipophilicity, In the brain, the labile 
dihydropyridine should be oxidized into the pyridiium salt. The BBB prevents rediffision of 
the polar pyridinium compound, which results in an increased and sustained brain 
concentration. 
In view of this, we are engaged in investigations regarding the preparation of Tc complexes 
containing the pyridiniumldihydropyridine moiety, their electrochemical behaviour and 
characterization in biological Systems in vitro and in vivo, and have chosen 1-methyl-3- 
carbamoyl-1,4-dihydropyridine (MCD) as the pilot compound for preliminary studies. 
Nicotinic acid derivatives and vitarnins of the B group react with dehydrogenases. Initial rate 
and inhibition studies of the enzyrne reaction of lactate dehydrogenase (LDH) ( l a c t a t e : ~ ~ ~ '  
oxidoreductase, EC 1.1.1.2) were canied out in the absence and presence of MCD+ to obtain 
infomation about the type of inhibition of MCD+, the kinetic constants and the possible 
reduction of MCD+. 
The inhibition of the LDH by N-methyl-nicotineamide-iodide (MCD~) was measured by the 
reactions (1) lactate + NA& + M C D ~  # pyruvate + W H  + with trapping of the 
pyruvate by the reaction (2) pyruvate + L-glutamate # L-alanine + Zoxoglutarate. 
A t w  step synthesis of l-methyl-3-carbamoyl-1,4-dihydrop~~me was carried out according 
to [6] in a rnodified procedure: quatemisation of nicotinamide (1) to form 1-methyl-3- 
carbamoyl-mdinium iodide (2) followed by reduction of the quaternary salt, produced 1- 
meth~-ld-carbmoyl-l,4-dihydro~dine WCDHI2) (4). Reduction with sodium dithionite in a 
sIightIy alkaline medium occurs via sulphinate adduct (3) [7]. 
The reaction was monitored by thin layer chromatography and W spectroscopy at intervals of 
5 min. For the chromatographic System and the RF values see below. Fig. 1 shows the IJV 
spectrum of (4) in diethylether (a) and in buffer pH 7 (b) after 30 min. 
Fig. 1. The spectrum of I-m~fhyl-3-cafgarnog1-3.~C 
Experiments 
I.  I-methyl-3-carbamoyl-pyridinium iodide (2) 
3g (0,024mol) nicotinamide was dissolved in 15ml of warm methanol. To this solution 3ml 
(0,46mol) of methyl iodide was added and the mixture was refluxed for 30min. After cooling 
the yellow residue was separated and crystallised from a mixture of 50ml of methanol and 5ml 
of water. 
Yield: 3,Sg (54%); mp 2060C (Ref. 203-2040C [SI) 
Thin layer chromatography: chromatographic system: 
Silufol//n-butanoVacetic acidwater 2: 1 : 1 RF 0,25 (UV, 254nm) 
UVmm (water) 265nm; 270nm, sh 
IR W r ) :  VCH3 2980, VC=O 1695cm- 1 
IH-NMR (DMS0)TMS 6 4.41 (N-CH3,3H); 6 8.23-8.28 (Cg-H,lH) 
6 8.89-8,93 (C4-H, 1H); 6 9.1 1-9.13 (Cg-H, 1H) 
6 9.41 (C2-H, 1H) 
2. I-methyil-3-carbamoyl-I,4aihydropyridine (4) 
To a solution of 2.668 (O.Olmo1) of (2) in 2001111 of bidistilled water 5g (0.06mol) of sodium 
bicarbonate was added. The mixture was stirred in an ice bath under nitrogen and 7.lg (0.04 
mol) sodium dithionite was added. Stirring and cooling under nitrogen was continued for 30 
min and then the mixture was extracted with 200ml diethylether. The ether layer was 
separated, dried with sodium sulphate and the yellow oily residue was isolated by freeze- 
drying. 
During the reaction time samples of 31x11 were taken, extracted with 3ml diethylether and the 
ether layer was investigated by W spectroscopy and thin layer chromatography. 
Yiefd: 0.99g (72%). The product was found to be relatively unstable as regards-oxidation by 
air. 
Thin layer chmatography: chromatographic system: 
SilufoV/n-butanoVacetic acidfwater 2: 1 : 1 RF 0.2 OJV, 366nm) 
(dieihylether) 3 50nm; 
Wmax (buffer pH 7) 290nm, 360nm 
1~ S 3.13 (N-CH3,3H); 6 3.25 (Ch2,2H) 
6 4.91-4.97 (Cs-IS, 133; 6 5.94-5.99 (C6-H, 1H) 
6 7.13 (Q-WIH) 
II. I I N H I B I ~ N  OF LACTATE DEHYDROGENASE BY N-MET~L-NICOT~E AMIDE 
Materials and Methoh 
NAD+, L-glutamate and carbonate were purchased from Boehringer Mannheim. L-lactate was 
obtained fi-om SERVA. The LDWGPT enzyme solution was obtained from Boehringer 
Mannheim (Test-combination L-lactic acid). Proteins were detemiined by the biuret or Lowry 
method. 
Kinetic meamrements 
Kinetic measurements were carried out at 20°C in 25 rnM carbonate buffer, pH 10, 23mM 
L-glutamate. The solution of the coenzymes, the MCD+ and L-lactate were prepared daily. In 
these solutions the concentrations of NAD+ and NADH were directly deterniined by the 
absorbance at 260 and 340nm, respectively, and those of the substrates by optical enzymatic 
methods. 
The initial rates were measured in a total volume of 1 ml. The enzyme concentration was held 
constant throughout all experhents: an enzyme activity of 15U was added per test. The 
changes of absorbance at 340nm were recorded by a SECOMAM SlOOO photometer (optical 
path: Icm, scale expansion O.1A). The reaction was started by addition ofL-lactate. 
Data processing 
A preliminary graphical analysis showed that the kinetic data foiiow the general equatlran 
v=VS/(K+S) [10]. Hence, the least-squares method was applied and the EXCEt 3.0 an#or 
SPSS program was used to fit the kinetic data to an equation of the form y - a + fi. Thfi 
weights were taken as wi = 1/6i . ,  where cZi s the sarnple variance ofthe ith observation. 
For the primary plots, the observed reciprocal velocities (yj) were ploted versus reciprocal 
substrate concentrations (~i). In this case the calculation provides the apparent ~ ä l u e ~  of 
fil/V; K and V,  with their estimated variances. In order to obtain signislcan-t. fits* the da@ were 
obtained at least in triplicate for each substrate concentration over a ran e of four t~ ifivf: 
concentrations. 
For the secondary plots, the observed values of 
the reciproca] concentrations of the substrates. 
Resuits 
Initial rate studies 
Initial rate studies were carried out on the enzyme in & &rection ~ f t h e  r e a~~oa  
each substrate concentration for at least four fixed concentratiarn 
From these data w o  primary linear Lmeweaver-Burk 
(Ilb, lc, 2b, 2c). These replots were also linear and provided the best estimates of the two 
Michaelis constants @Iactate, K N ~ ~ + ) ,  the dissociation constant of the NAD' (Ks ~ ( N A D ) )  
and of the maximum rate (VaPP,=), In the Table 1 the values of the Michaelis constants are 
given in Tab. 1. 
1mAD concentration [Ummol] 
Fig. la: Lineweaver & Burk diagram of the LDH kinetic at different lactate concentrations 
(a: lmmol/l, b: 2mmoV1, C: 5mmol/i, d: 10mmoV1). 
Mactate concentration [Vmmol] 
Fig 1 b: Determination of the dissociation constants by the slope method. The dope of the 
graphs of Fig. la are plotted versus there reciprocal lactate concentrations. 
I 
Fig I C: Determination of the dissociations constants, The rdatEve b m  rri.aan0 
1Aactafe coneentration [Vmmol] 
Fig. 2a: Lineweaver & Burk diagram of the LDH kinetic at different NAD+ (a: 46pmoM, 
b: 92pmoV1, C: 230pmoV1, d: 460pmoV1, e: 920pmoVl). 
INAD concentration [Vmmol] 
Fig 2c: Determination of the dissociations constants. The relative maximum reacikm ratm 
found as intercepts in the Fig l a  are plotted as a function of the r ec ip rd  lactate 
concentration. d 
Inhibition studies 
MCD+ and the variable substrate is NAD', the infnbition type appears to be a competitive One 
(Fig 3). But there is no significant distiiction from the non-competitive type. Further 
investigations are necessary to clariq the inhibition type, 
Tab. 1 : Kinetic Parameters of lactate dehydrogenase 
Fig 3: Determination ofthe dissociation constant of the MCD enzyme complex by the Dixon plot 
of the LElH i'emtion. Tfie reciprocal reaction rates are plotted as funetions of the MCD 
concentrsntion at diierent NAB+ concentrations (a 46 pmoV1, b 92 pmoY1, C 230 p o u ,  
Tb disso&ation cwsfsunt $) is 350 times higher than the %+. mDH2 does not 
inhibit the 
consistent 
complex. 
LDH reaction. MCD+ is not reduced by LDH. The kinetic Pattern of the enzyme is 
with a mechanism of the Theorell-Chance type, with a kinetically irrelevant ternary 
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27. ELECTROCHEMICAL REDUCTION OF 1-METHYL-3-CARBAMOYL- 
PYRIDnurrriM IODIDE 
I. Hoffmann, H. Spies, B. Johannsen 
The dihydropyridinelpyridinium system may be potentially useful for trapping Tc tracers in 
the brain. We are therefore interested in the electrochemical behaviour of the dihydro-pyri- 
dinelpyridinium system and investigated the reduction of 1-meth~l-3-carbmo~1p'~ridinium 
iodide in various aqueous solutions at different pH using polarographic, voltammetric, 
coulometric and spectrophotometric methods. 
Chemicals 
l-methyl-3-carbamoylpyridinium iodide [mp = 207-209°C; UV max (H20) 265nmJ 
supporting electrolytes: 0.1M KC1 pH = 5.3; phosphate buffer (Sörensen) pH = 7.0; 
Britton-Robinson buffer pH = 9.1 ; 0.1M Me4NOHiO. 1M Me4NCl 
All solutions were deoxygenated by argon (99.998%). 
Apparatus 
DCIAC polarograph ( G W  673, ZWG Berlin); Cyclic voltammograph (CV-27, BAS); 
UV-WS spectrophotometer (Specord M40, Carl Zeiss Jena) 
Electrodes 
working electrodes: static mercury drop electrode (GQE 100, ZWG Berlin), 
glassy carbon electrode; 
reference eliectrode: saturated calomel electrode; Counter electrode: Pt or Hg-pool 
Results and discussion . 
DC polarog~ams of l-methyl-3-carbamoylpyridinium iodide were recorded in various solu- 
tions (Fig.1). All curves show two cathodic reduction waves. The changes in height of the 
by different wncentrations. The half wave potentids of the first wave are 
of the second wave d*er from each other. It can be assumed that these 
differentes result from adsorption of reaction products which increase the resistance to 
charge transfer at the elec surface, combined with an overvoltage. In phosphate solu- 
tion a mcwllanum is superimposed on the second wave. In 0.1M Me4NOHIO. 1M Me4NC.l 
e1ectroIyte, a low additionai wave can be observed near the first wave. 
Cyclic voltammograms were recorded at the 
hanging mercury drop electrode and the 
glassy carbon electrode. In aU tested solutions 
a reduction peak is found in the potentiai 
range of the first wave of the dc polarogram 
at about -1000 mV (Figs. 2, 3). In the poten- 
tial range of the second wave (-1700 mV) a 
low reduction peak was only ubserved in the 
I 
I Me4NOHl Me4NCl solution. In this supprt- 
I ing .electrolyte an additional peak exists in 
I the potential range of the first ' wave (- 
I 
I 
I 
I 
.. 1250mV). AU reduction steps are irreversi- 
ble. The anodrc oxidation peak (Figs. 2, 3) 
may be due to the formation of dimeric po -  
-1000 -1500 -2000 
Volta& ScE b V l  ducts [I]. 
Electmlyses of l-methyl-3-carbamoylpyridinium iodide in the potential region of the seeond 
wave were performed in Britton-Robinson buffer and in the Me4NOHIMe4NCl system. 
Reduction was carried out at the stirred mercury pol. During reaction the yellow colour of 
the solution in the cathodic compartment became more intensive. 
In Britton-Robinson buffer two maxima are observed in the UV spectrum at 278 and 300nm 
after reduction. A dark precipiitate is formed in the anodic compartment, The solution of 
this precipitate in ether shows a maximum in UV at 350nm, which is characteristic of 
dihydropyridine [I]. 
In the Me4NOHIMe4NCl solution no insoluble products were observed during coulometry 
at -1900mVlSCE. The polarograms of pyridinium (1) and after partial, (2, 3, 4) and nearly 
complete reduction (5) are depicted in Fig. 4. Fig. 5 shows the UV spectra of diluted solu- 
tions 
corresponding to the polarogranns in Fig. 4. The UV maxima at 270nm and 357nm indicate 
the formation of a dihydro-pyridinium compound [I]. 
In the dc polarogram (Fig. 4) the first 
i b A 1  reduction wave consists of two parts 
whose relation changes during re- 
40 
duction. This behaviour could be ex- 
plained by formation of isomeric re- 
duction products. An anodic wave in- 
creases on nearly the sarne scale, corre- 
sponding to the anodic peak of the cyc- 
lic voltarnmogram in Fig. 3. The anodic 
step is described in the literature in 
connection with the existence of dimeric 
- products [I]. 
From these coulometric measurements 
at -1900mVfSCE the electron transfe- 
-500 -1000 - isa, -2000 rence A b e r  of two is deteimined for 
voltage SCE [mv the second wave. 
Fig. 4: C~d0mei.Xi~ reduction ~f l-methyl-3-~arbamo~l~~ridi~i~~ io de in Me4NOH/ 
MeyCi; (C = 5 . 5 a ;  Hg-pl;  voltage = -1g(J)mV~c~) 
Fig. 5: Changing of W-spectra caused by reduction of 1-metbyl-3-carbamoylpyndinium 
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is, charactekation and ~oiecular stmcturiv ofnitndotecfuietium(v) complexes ~ 4 t h  
Pietzsch, H.-J., F. E. Hahn, A. Dittler-Klingemann, H. Spies 
Synthesis, characterization and molecular structure of Tc(II1) complexes with the tripodal lig- 
and tris-(2-mercaptoethy1)amin 
29th International Conference on Coordiiation Chemistry (ICCC), Lausanne, l9.-24. Juli 1992 
Pietzsch, H.-J., H. Spies, S. Seifert, R, Syhre, B. Johannsen 
Technetium thioetherlthiolato complexes: A new class of cationic compounds 
European Association of Nuclear Medicine Congress 1992, 
Lissabon, Portugal, 22. -26.8.1992 
Pietzsch, H.-J., H. Spies, P. Leibnitz, G. Reck 
Synthesis, characterization and molecular structure of nitridotechnetium(V) complexes with 
thiacrown ethers 
Tagung der Deutschen Kristallographischen GesellschaR, Bochum, November 1993 
V. 
SCIENTIFIC COOPERATION 
In multidisciplinary rescearch such as carried out by this Institute, collaboration, the sharing 
of advanced equipment and, above all, exchanges of ideas and information obviously play 
an important role. Effective collaboration has been established with colleagues at universi- 
ties, in research centres and hospitals. 
Cooperative relations and joint projects 
The Technische Universitiit Dresden (Dr. Scheller, Inst. of Analytical Chemistry) plays an 
essential part in SPECT tracer research by performing analytical characterization of new 
tracers and providing support with the synthesis of organic compounds P r .  Habicher, Inst. 
of Organic Chemistry) . 
Very effective cooperation also exists with the Bundesanstalt für Maierialforschung Berlin 
(far. Reck, Mr. Leibnitz) who have camed out X-ray crystal structure analysis of new tech- 
netium and rhenium complexes. 
Our long-standing cooperation with the University of Padua (Prof. Mazzi) and the 
"Demokntos" National Research Centre for Physical Sciences in Athens (Dr. Chiotellis) has 
noiw been instrumental in advancing the chemistry of thioether complexes. 
Joint work on technetium complexes with tripodal ligands has been carried with the Freie 
UniverSit& Berlin (Prof. Hahn, Inst. of Inorganic and Analytical Chemistry). 
Cooperation on a special research topic concerning technetium tracers is in Progress with 
the Fodungszentrum Jülich (Prof. S töcklin) . 
Common objects of radiopharmacological and medical research link the Institute with the 
Medizinische Akademie 'Cad Gustav Carusv Dresden, above all with its Departments of 
Nuclm Medicine (Prof. Franke), Psychiatry (Prof. Felber), Neurology (Prof. Kunadt) and 
Glkical Chemistiy (Prof. Jaroß, Dr. Bergmann). A joint team of staff members from both 
the Institute and the Academy's Clinic of Nuclear Medicine are currently working at the 
IiMssendorf PET centre. 
Identification of commoln objecfives in technetium radiopharmacy has led to collaborative 
resemh with the Hu~bolrU-Universität Berlin P r .  Michael of the "Chante" Hospital's 
Clinic of Nuclear Medicine) and with the Bundesgesundheutsamt Berlin (Dr. Schüttler). 
C10se coopration exists with the Montreal Neurologicai Institute (Prof. Gjedde, Prof. 
Thomgson), Canada, h the field of PET lmage data reconstruction and phamacological 
studies. 
Wiebe, Edmonton, Canada; Prof. Meyer, Hannover) and technetium tracers (Dr. Brandau, 
Münster; Prof. Mäcke, Basel, and Prof. Wenzel, FU Berlin). The time and effort given by 
Prof. Thompson, Canada, to setting up the "Positome IIIp" positron camera is highly ap- 
preciated. 
Fruitful collaboration with the Institut für Diagnostikforschung, Berlin, is focused on 
technetium complexes with selected ligands. 
IAEA Fellowship Training 
Mr. M-Rahman and Mr. A.Haque from the Bangladesh Atomic Energy Commission, 
Dhaka, completed a fellowship training in Rossendorf from 31 March to 16 August 1992. 
The programme included Tc-99m kit production and quality control, ligand synthesis asi 
well as manufacturing Tc-99m generators based on both (n,y)- and fission Mo-99 molybde- 
num. 
The training programme was arranged and supervised by the VKTA' s Radiopharinaceuticd 
Laboratory in conjunction with our Institute. 
DAAD Scholarship 
Mr. I. Suparman from the Indonesian National Atomic Energy Agency , Radioisotope pro- 
duction Centre, Jakarta, stayed in Rossendorf from 31 May to 29 November 1%% 
performed studies on garnrnmaspectrometric determination of U-235 uranium in S W ' ~ U % ~ %  of 
fission products. He also investigated the adsorption of molydenum on vdous absorbent 
materials and prepared a speciai documentation on Tc-99m generator parametersi 
The research assignment was arranged by the VKTA' s ~adiophma~euficZd h b o r a t 0 ~  d 
Waste Department in conjunction with our Institute. 
W. 
SEMINARS 
Dr. W. Brandau, Universität Münster 
Neue NxSy-Liganden für 99m~c und neue iodmarkierte Fettsäuren 
22. Januar 1992 
Prof. M. Wenzel, FU Berlin 
Radioaktive Metallocenderivate als potentielle Radiopharmaka 
31. März 1992 
Dr. Rozyan Yazid, Indonesien 
Radioproduction Center in Jakarta - production program and facilities 
5. Mai 1992 
Dr. P. Brust, Universität Leipzig 
Untersuchungen von ausgewählten Himfuktionen mit PET 
12. Mai 1992 
Prof.G.-J. Meyer, Hannover 
Die Herstellung von PET-Radiopharmaka: Probleme der Zulassung und Anwendung 
22. Juni 1992 
Dr,Pigeot/Dr.Kübler, Universität Dortmund 
Einbeziehung biometrischer Methoden in die Planung biologischer Experimente 
Prof. G .  Firnctu, Hamilton, Kanada 
Wie man mit der Positronen-Emissions-Tomographie dopaminerge Areale im Gehirn unter- 
20, August 9992 
BrgahadereUe Freiberg 
Prof. L.I. Wiebe, Ekimonton, Kanada 
Hypoxic Cell Sensitizers for Diagnostic Scintigraphy of Tissue Hypoxia 
2. Oktober 1992 
Dr. D. Scharnweber, Rossendorf 
Anwendung der Impedanzspektroskopie in biologischen Systemen 
9. Oktober 1992 
Prof. H. Mäcke, Univ. -Klinik, Kantonsspital Basel 
Chemische Aspekte der Markierung von Biomolekülen mit metallischen Radionukliden 
23. Oktober 1992 
Prof.. C. Gloe, Inst. f. Festkörper- U. Werkstofforschung DresdenJTU Dresden 
Extraktion von Metallionen mit cyclischen und offenkettigen Schwefelvesbuidungen 
30. Oktober 1992 
Dr. M. Findeisen, Institut für Oberfiächenmodif~iening Leipzig 
NMR-Spektroskopie an Technetiurnkomplexen 
3. November 1992 
Dr. Ostertag, Deutsches Krebsforschungszentnim Heidelberg 
Physikalische Voraussetzungen quantitativer PET-Messungen 
12. November 1992 
OA Dr. M. Cordes, Univ.-Klinikum Berlin-Charlottenburg 
PET in der Neurologie, Onkologie und Kardiologie 
20. November 1992 
vn. 
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The Institute is part of the Research Center Rossendorf Inc, which is financed by the Fed- 
erd Republic of Germany and the Free State of Saxony on a fiQ-fifty basis. 
In addition, the Free State of Saxony provided support for three projects (FZRl3, FZR19 
and FZR/ 17) covering the installation of positron emission tomography (PET), improved 
analytical equipment and measures required to meet legal standards for radiochemical labo- 
ratories. 
The research projects concerning technetium compounds and transport systems were sup- 
ported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. 
A one-year project on characterization of radiotracers preparatory to, and for the purpose 
of, reducing the number of animai studies was facilitated by financial and material support 
provided within a scientific job-creating Programme (ABM). 
The work on technetium chemistry was supported in part by a contract with the Institut für 
Diugnostikforschung, Berlin. 
Prof. Stöclclin, Jiilich, has continued assist us in the process of setting up the Institute. 
A major step forward to the establishment of a PET centre was possible thanks to a special 
offer by Professors Gjedde and Thompson, Canada, concerning the "POSITOME IiIp" 
camera, and fiancial support provided for this by the K u l t u ~ ~ u n g  Dresden der Dresdner 
Bank 
The ungszentncm Karlsruhe @r. Schweickert, Dr. Bechtold of the Cyclotron 
Depamnent) assigned a technology tranfer project on 123~-radiopharmceuti~als to a group 
asswiated with the Insthte. 
Pending the awad of a licence for radioactive work at Rossendorf, laboratories outside our 
sly he1M to overcome the dtical situation. We are particularly indebted 
boMt Univedtät and the Medizinische 
